| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 153 | 2026 | 757 | 33.510 |
Why?
|
| Blood Preservation | 99 | 2026 | 354 | 23.790 |
Why?
|
| Metabolomics | 100 | 2026 | 727 | 15.860 |
Why?
|
| Metabolome | 55 | 2026 | 384 | 11.310 |
Why?
|
| Erythrocyte Transfusion | 38 | 2026 | 231 | 9.560 |
Why?
|
| Proteomics | 79 | 2026 | 1195 | 8.140 |
Why?
|
| Hemolysis | 33 | 2026 | 243 | 7.700 |
Why?
|
| Glycolysis | 60 | 2026 | 339 | 6.660 |
Why?
|
| Blood Donors | 26 | 2026 | 143 | 5.770 |
Why?
|
| Proteome | 34 | 2025 | 518 | 5.660 |
Why?
|
| Anemia, Sickle Cell | 19 | 2026 | 312 | 5.470 |
Why?
|
| Oxidative Stress | 54 | 2026 | 1339 | 5.400 |
Why?
|
| Glucosephosphate Dehydrogenase | 17 | 2026 | 69 | 5.010 |
Why?
|
| Shock, Hemorrhagic | 14 | 2023 | 201 | 4.470 |
Why?
|
| Blood Transfusion | 18 | 2026 | 405 | 4.030 |
Why?
|
| Mass Spectrometry | 37 | 2026 | 750 | 3.530 |
Why?
|
| Animals | 254 | 2026 | 38058 | 3.450 |
Why?
|
| Energy Metabolism | 30 | 2025 | 935 | 3.370 |
Why?
|
| Humans | 458 | 2026 | 144759 | 3.190 |
Why?
|
| Blood Platelets | 20 | 2026 | 400 | 3.020 |
Why?
|
| Plasma | 11 | 2026 | 225 | 3.000 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 10 | 2025 | 34 | 2.950 |
Why?
|
| Pentose Phosphate Pathway | 17 | 2024 | 55 | 2.840 |
Why?
|
| Mice | 151 | 2026 | 18339 | 2.830 |
Why?
|
| Transfusion Medicine | 7 | 2026 | 16 | 2.620 |
Why?
|
| Leukemia, Myeloid, Acute | 26 | 2026 | 682 | 2.610 |
Why?
|
| Hypoxia | 23 | 2026 | 1199 | 2.540 |
Why?
|
| Blood Proteins | 13 | 2020 | 249 | 2.520 |
Why?
|
| Wounds and Injuries | 18 | 2026 | 956 | 2.490 |
Why?
|
| Leukocyte Reduction Procedures | 9 | 2025 | 29 | 2.280 |
Why?
|
| Glucose | 23 | 2026 | 1047 | 2.110 |
Why?
|
| Hematopoietic Stem Cells | 14 | 2026 | 420 | 2.060 |
Why?
|
| Oxidation-Reduction | 36 | 2025 | 1087 | 2.030 |
Why?
|
| Glutathione | 23 | 2026 | 375 | 2.000 |
Why?
|
| Mitochondria | 31 | 2026 | 984 | 1.980 |
Why?
|
| Fatty Acids | 18 | 2025 | 450 | 1.950 |
Why?
|
| High-Throughput Screening Assays | 6 | 2021 | 175 | 1.930 |
Why?
|
| Male | 193 | 2026 | 72315 | 1.920 |
Why?
|
| Biomarkers | 39 | 2026 | 4271 | 1.910 |
Why?
|
| Platelet Transfusion | 6 | 2026 | 80 | 1.910 |
Why?
|
| Amino Acids | 17 | 2025 | 521 | 1.910 |
Why?
|
| Membrane Lipids | 5 | 2021 | 83 | 1.900 |
Why?
|
| Isotope Labeling | 4 | 2026 | 82 | 1.880 |
Why?
|
| Blood Banks | 8 | 2021 | 50 | 1.780 |
Why?
|
| Purines | 11 | 2023 | 187 | 1.730 |
Why?
|
| Drosophila melanogaster | 12 | 2026 | 236 | 1.710 |
Why?
|
| Chromatography, High Pressure Liquid | 19 | 2020 | 594 | 1.680 |
Why?
|
| Muscle, Skeletal | 19 | 2025 | 1795 | 1.620 |
Why?
|
| Female | 183 | 2026 | 78271 | 1.620 |
Why?
|
| Pyruvate Kinase | 7 | 2025 | 28 | 1.590 |
Why?
|
| Mice, Inbred C57BL | 56 | 2026 | 5992 | 1.580 |
Why?
|
| Carnitine | 7 | 2025 | 90 | 1.560 |
Why?
|
| Kynurenine | 9 | 2024 | 114 | 1.550 |
Why?
|
| Pancreatic Neoplasms | 10 | 2025 | 919 | 1.550 |
Why?
|
| Aging | 17 | 2025 | 1966 | 1.500 |
Why?
|
| Caffeine | 2 | 2025 | 74 | 1.500 |
Why?
|
| Cellular Reprogramming | 8 | 2021 | 103 | 1.460 |
Why?
|
| Meat | 5 | 2014 | 93 | 1.450 |
Why?
|
| Lymph | 6 | 2024 | 31 | 1.440 |
Why?
|
| Adult | 117 | 2026 | 40449 | 1.430 |
Why?
|
| Altitude Sickness | 6 | 2020 | 141 | 1.380 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 384 | 1.370 |
Why?
|
| Drosophila Proteins | 10 | 2025 | 212 | 1.370 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 378 | 1.370 |
Why?
|
| Neoplastic Stem Cells | 15 | 2026 | 412 | 1.340 |
Why?
|
| Arginine | 6 | 2024 | 262 | 1.340 |
Why?
|
| Iron | 8 | 2025 | 359 | 1.320 |
Why?
|
| Signal Transduction | 32 | 2025 | 5226 | 1.320 |
Why?
|
| Cryopreservation | 7 | 2018 | 110 | 1.300 |
Why?
|
| Receptor, Adenosine A2B | 4 | 2025 | 65 | 1.300 |
Why?
|
| Carbon | 7 | 2023 | 203 | 1.290 |
Why?
|
| Pandemics | 6 | 2023 | 1694 | 1.270 |
Why?
|
| Succinic Acid | 5 | 2020 | 42 | 1.260 |
Why?
|
| Inflammation | 28 | 2026 | 2878 | 1.250 |
Why?
|
| Disease Models, Animal | 39 | 2026 | 4557 | 1.250 |
Why?
|
| Hemoglobins | 9 | 2025 | 384 | 1.240 |
Why?
|
| Hypertension, Pulmonary | 15 | 2026 | 1980 | 1.230 |
Why?
|
| Drug Resistance, Neoplasm | 13 | 2026 | 881 | 1.210 |
Why?
|
| Blood Coagulation Disorders | 5 | 2023 | 189 | 1.200 |
Why?
|
| Liver | 21 | 2026 | 1887 | 1.200 |
Why?
|
| Neural Stem Cells | 3 | 2026 | 166 | 1.180 |
Why?
|
| Altitude | 7 | 2026 | 473 | 1.180 |
Why?
|
| Choline | 9 | 2024 | 136 | 1.170 |
Why?
|
| Biochemistry | 4 | 2015 | 36 | 1.160 |
Why?
|
| Exercise Tolerance | 4 | 2025 | 283 | 1.160 |
Why?
|
| Polyamines | 5 | 2024 | 42 | 1.150 |
Why?
|
| beta-Thalassemia | 6 | 2025 | 40 | 1.140 |
Why?
|
| Cattle | 11 | 2022 | 1000 | 1.130 |
Why?
|
| Cell Line, Tumor | 41 | 2026 | 3540 | 1.130 |
Why?
|
| Erythrocyte Membrane | 7 | 2022 | 54 | 1.130 |
Why?
|
| Oxygen | 18 | 2026 | 995 | 1.120 |
Why?
|
| Sciuridae | 3 | 2020 | 152 | 1.120 |
Why?
|
| Time Factors | 35 | 2025 | 7173 | 1.100 |
Why?
|
| Cysteine | 3 | 2025 | 210 | 1.090 |
Why?
|
| Lactic Acid | 9 | 2024 | 302 | 1.090 |
Why?
|
| Food Analysis | 3 | 2012 | 24 | 1.080 |
Why?
|
| Adenosine Triphosphate | 16 | 2025 | 498 | 1.070 |
Why?
|
| Immunomodulation | 3 | 2025 | 101 | 1.060 |
Why?
|
| Macrophages | 19 | 2026 | 1511 | 1.060 |
Why?
|
| Muscle Proteins | 6 | 2019 | 244 | 1.040 |
Why?
|
| Stearoyl-CoA Desaturase | 3 | 2024 | 66 | 1.040 |
Why?
|
| Lipid Metabolism | 14 | 2026 | 527 | 1.040 |
Why?
|
| Erythrocyte Aging | 5 | 2025 | 12 | 1.030 |
Why?
|
| Liver Transplantation | 16 | 2025 | 823 | 1.020 |
Why?
|
| Drug Discovery | 4 | 2013 | 155 | 1.020 |
Why?
|
| Interleukin-6 | 3 | 2026 | 780 | 0.990 |
Why?
|
| Tumor Suppressor Protein p53 | 10 | 2026 | 529 | 0.990 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 3 | 2021 | 23 | 0.990 |
Why?
|
| Rejuvenation | 4 | 2024 | 18 | 0.980 |
Why?
|
| Balloon Occlusion | 2 | 2024 | 39 | 0.980 |
Why?
|
| Protein Processing, Post-Translational | 8 | 2025 | 477 | 0.970 |
Why?
|
| Polymorphism, Genetic | 4 | 2026 | 612 | 0.970 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2025 | 291 | 0.970 |
Why?
|
| Neoplasm Proteins | 4 | 2025 | 442 | 0.970 |
Why?
|
| Tryptophan | 8 | 2024 | 181 | 0.960 |
Why?
|
| Reactive Oxygen Species | 15 | 2025 | 621 | 0.960 |
Why?
|
| Lipogenesis | 2 | 2026 | 62 | 0.950 |
Why?
|
| Multiple Trauma | 2 | 2024 | 116 | 0.940 |
Why?
|
| Resuscitation | 7 | 2026 | 302 | 0.920 |
Why?
|
| Transfusion Reaction | 2 | 2025 | 63 | 0.920 |
Why?
|
| Protein D-Aspartate-L-Isoaspartate Methyltransferase | 2 | 2023 | 5 | 0.910 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2025 | 5 | 0.900 |
Why?
|
| Rh-Hr Blood-Group System | 2 | 2023 | 14 | 0.900 |
Why?
|
| Adaptation, Physiological | 7 | 2025 | 570 | 0.890 |
Why?
|
| Adenine | 4 | 2022 | 339 | 0.880 |
Why?
|
| Refrigeration | 4 | 2025 | 12 | 0.870 |
Why?
|
| 2,3-Diphosphoglycerate | 10 | 2026 | 32 | 0.870 |
Why?
|
| Fluid Therapy | 3 | 2026 | 147 | 0.870 |
Why?
|
| CD8-Positive T-Lymphocytes | 10 | 2025 | 917 | 0.840 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2023 | 653 | 0.840 |
Why?
|
| Middle Aged | 72 | 2026 | 35875 | 0.830 |
Why?
|
| Endothelium, Vascular | 10 | 2025 | 965 | 0.830 |
Why?
|
| Sodium Chloride | 3 | 2014 | 141 | 0.830 |
Why?
|
| Alzheimer Disease | 4 | 2023 | 621 | 0.820 |
Why?
|
| Metals, Heavy | 1 | 2024 | 31 | 0.820 |
Why?
|
| Mutation | 23 | 2026 | 4089 | 0.820 |
Why?
|
| Blood Group Antigens | 1 | 2023 | 15 | 0.820 |
Why?
|
| Hemoglobin SC Disease | 1 | 2023 | 14 | 0.820 |
Why?
|
| Cellular Senescence | 7 | 2026 | 226 | 0.820 |
Why?
|
| Uric Acid | 1 | 2025 | 166 | 0.800 |
Why?
|
| Proteostasis | 3 | 2025 | 27 | 0.800 |
Why?
|
| Hematopoiesis | 6 | 2025 | 194 | 0.790 |
Why?
|
| Sickle Cell Trait | 1 | 2023 | 15 | 0.780 |
Why?
|
| Hypocalcemia | 1 | 2023 | 38 | 0.780 |
Why?
|
| Metabolic Networks and Pathways | 10 | 2026 | 187 | 0.770 |
Why?
|
| Physical Conditioning, Animal | 2 | 2025 | 243 | 0.770 |
Why?
|
| Blood Coagulation | 8 | 2026 | 268 | 0.770 |
Why?
|
| Blood Component Transfusion | 4 | 2026 | 103 | 0.770 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 7 | 2025 | 279 | 0.770 |
Why?
|
| Rats, Sprague-Dawley | 17 | 2026 | 2527 | 0.760 |
Why?
|
| Hibernation | 3 | 2020 | 80 | 0.760 |
Why?
|
| Thrombosis | 6 | 2026 | 393 | 0.750 |
Why?
|
| Endothelial Cells | 12 | 2025 | 869 | 0.750 |
Why?
|
| Citric Acid Cycle | 7 | 2021 | 59 | 0.750 |
Why?
|
| Equidae | 1 | 2022 | 7 | 0.750 |
Why?
|
| Organ Preservation Solutions | 9 | 2014 | 47 | 0.740 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2020 | 321 | 0.730 |
Why?
|
| Diethylhexyl Phthalate | 3 | 2024 | 15 | 0.720 |
Why?
|
| Testosterone | 2 | 2023 | 419 | 0.720 |
Why?
|
| Healthy Volunteers | 9 | 2022 | 215 | 0.710 |
Why?
|
| Isoaspartic Acid | 1 | 2021 | 3 | 0.710 |
Why?
|
| Athletic Performance | 1 | 2023 | 76 | 0.710 |
Why?
|
| Glycerophospholipids | 1 | 2022 | 39 | 0.710 |
Why?
|
| Renal Insufficiency | 2 | 2022 | 168 | 0.700 |
Why?
|
| Erythropoietin | 1 | 2022 | 100 | 0.700 |
Why?
|
| Models, Biological | 11 | 2026 | 1821 | 0.690 |
Why?
|
| Oxidative Phosphorylation | 13 | 2026 | 210 | 0.690 |
Why?
|
| Swine | 7 | 2024 | 833 | 0.690 |
Why?
|
| Glutamine | 7 | 2026 | 109 | 0.690 |
Why?
|
| Neoplasms | 10 | 2024 | 2875 | 0.680 |
Why?
|
| Erythroblasts | 4 | 2025 | 19 | 0.680 |
Why?
|
| Extracellular Vesicles | 5 | 2025 | 171 | 0.680 |
Why?
|
| Xanthine | 2 | 2020 | 7 | 0.680 |
Why?
|
| Prenatal Exposure Delayed Effects | 8 | 2025 | 675 | 0.670 |
Why?
|
| Rats | 23 | 2026 | 5597 | 0.670 |
Why?
|
| Fatty Acid Desaturases | 1 | 2021 | 31 | 0.670 |
Why?
|
| Bacterial Infections | 2 | 2021 | 246 | 0.660 |
Why?
|
| Blood Chemical Analysis | 3 | 2010 | 109 | 0.660 |
Why?
|
| Lysophospholipids | 5 | 2023 | 77 | 0.660 |
Why?
|
| Systems Biology | 3 | 2025 | 72 | 0.660 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 5 | 2023 | 266 | 0.660 |
Why?
|
| Phosphates | 4 | 2023 | 180 | 0.650 |
Why?
|
| Autophagy | 4 | 2025 | 286 | 0.650 |
Why?
|
| Running | 2 | 2022 | 228 | 0.650 |
Why?
|
| Zika Virus | 1 | 2022 | 132 | 0.650 |
Why?
|
| Milk Proteins | 2 | 2010 | 35 | 0.650 |
Why?
|
| Bile Acids and Salts | 6 | 2026 | 164 | 0.650 |
Why?
|
| Pancreatic Cyst | 1 | 2021 | 50 | 0.650 |
Why?
|
| Nitrogen | 3 | 2020 | 170 | 0.650 |
Why?
|
| Glucuronates | 1 | 2020 | 5 | 0.640 |
Why?
|
| Cell Death | 2 | 2020 | 383 | 0.640 |
Why?
|
| Coffee | 1 | 2020 | 15 | 0.640 |
Why?
|
| AMP-Activated Protein Kinases | 8 | 2025 | 190 | 0.630 |
Why?
|
| Adenosine | 14 | 2023 | 255 | 0.630 |
Why?
|
| Antineoplastic Agents | 12 | 2024 | 2194 | 0.630 |
Why?
|
| Quantitative Trait Loci | 5 | 2025 | 374 | 0.620 |
Why?
|
| Torpor | 2 | 2020 | 19 | 0.620 |
Why?
|
| Brain Death | 4 | 2016 | 60 | 0.620 |
Why?
|
| Taurine | 1 | 2020 | 41 | 0.620 |
Why?
|
| Cholesterol | 6 | 2024 | 406 | 0.620 |
Why?
|
| Gene Expression Regulation | 17 | 2024 | 2608 | 0.620 |
Why?
|
| Physical Exertion | 1 | 2021 | 207 | 0.610 |
Why?
|
| Zika Virus Infection | 1 | 2022 | 168 | 0.610 |
Why?
|
| Precision Medicine | 6 | 2026 | 457 | 0.610 |
Why?
|
| Biomarkers, Tumor | 3 | 2025 | 1313 | 0.610 |
Why?
|
| Parabiosis | 1 | 2019 | 11 | 0.600 |
Why?
|
| Kidney Transplantation | 19 | 2016 | 704 | 0.600 |
Why?
|
| Asparagine | 2 | 2018 | 35 | 0.600 |
Why?
|
| Erythrocyte Deformability | 4 | 2023 | 23 | 0.590 |
Why?
|
| Cholestasis | 4 | 2026 | 219 | 0.590 |
Why?
|
| Arousal | 2 | 2020 | 157 | 0.590 |
Why?
|
| Sulfonamides | 7 | 2025 | 580 | 0.580 |
Why?
|
| Fetal Development | 8 | 2024 | 299 | 0.580 |
Why?
|
| Citric Acid | 2 | 2016 | 34 | 0.580 |
Why?
|
| Nuclear Proteins | 5 | 2021 | 748 | 0.580 |
Why?
|
| Apoptosis | 16 | 2024 | 2430 | 0.570 |
Why?
|
| Mice, Knockout | 18 | 2025 | 3121 | 0.570 |
Why?
|
| Isoantibodies | 4 | 2026 | 57 | 0.570 |
Why?
|
| Adenocarcinoma | 3 | 2019 | 928 | 0.570 |
Why?
|
| Temperature | 4 | 2021 | 679 | 0.570 |
Why?
|
| Citrates | 2 | 2017 | 41 | 0.570 |
Why?
|
| Calcium | 9 | 2025 | 1183 | 0.560 |
Why?
|
| Aspartic Acid | 1 | 2018 | 88 | 0.560 |
Why?
|
| Gluconates | 1 | 2018 | 4 | 0.560 |
Why?
|
| Head and Neck Neoplasms | 4 | 2024 | 558 | 0.560 |
Why?
|
| Blood Specimen Collection | 1 | 2018 | 38 | 0.550 |
Why?
|
| Antacids | 1 | 2018 | 16 | 0.550 |
Why?
|
| Homeostasis | 9 | 2024 | 640 | 0.550 |
Why?
|
| Guanosine | 1 | 2018 | 40 | 0.550 |
Why?
|
| Complement System Proteins | 2 | 2021 | 316 | 0.540 |
Why?
|
| Exercise | 5 | 2025 | 2201 | 0.540 |
Why?
|
| Mesentery | 2 | 2014 | 45 | 0.540 |
Why?
|
| Hypoxanthine | 1 | 2017 | 11 | 0.540 |
Why?
|
| Hemoglobin, Sickle | 3 | 2023 | 19 | 0.540 |
Why?
|
| Chemical and Drug Induced Liver Injury | 3 | 2026 | 139 | 0.540 |
Why?
|
| Lipids | 8 | 2025 | 710 | 0.530 |
Why?
|
| Fetal Blood | 2 | 2010 | 342 | 0.530 |
Why?
|
| Ischemic Preconditioning | 1 | 2018 | 47 | 0.520 |
Why?
|
| Stress, Physiological | 3 | 2025 | 453 | 0.520 |
Why?
|
| Prognosis | 7 | 2025 | 4282 | 0.520 |
Why?
|
| Blood Glucose | 6 | 2026 | 2327 | 0.520 |
Why?
|
| Betacoronavirus | 4 | 2020 | 286 | 0.520 |
Why?
|
| Brain Injuries, Traumatic | 5 | 2024 | 441 | 0.520 |
Why?
|
| Multiple Sclerosis | 4 | 2024 | 484 | 0.520 |
Why?
|
| Tissue Donors | 10 | 2016 | 424 | 0.510 |
Why?
|
| Antioxidants | 6 | 2024 | 549 | 0.510 |
Why?
|
| STAT3 Transcription Factor | 3 | 2025 | 207 | 0.510 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 5 | 2025 | 297 | 0.510 |
Why?
|
| Mice, Transgenic | 10 | 2025 | 2182 | 0.500 |
Why?
|
| Leukemia | 4 | 2020 | 245 | 0.500 |
Why?
|
| Cadmium | 2 | 2015 | 69 | 0.500 |
Why?
|
| Ischemia | 4 | 2024 | 421 | 0.500 |
Why?
|
| Cell Proliferation | 19 | 2026 | 2496 | 0.500 |
Why?
|
| Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 7 | 0.490 |
Why?
|
| Breast Neoplasms | 7 | 2025 | 2452 | 0.490 |
Why?
|
| Mannitol | 3 | 2022 | 40 | 0.490 |
Why?
|
| Oxygen Consumption | 6 | 2025 | 724 | 0.490 |
Why?
|
| Cytokines | 10 | 2025 | 2061 | 0.490 |
Why?
|
| Carbon Isotopes | 3 | 2026 | 144 | 0.480 |
Why?
|
| RNA-Binding Proteins | 6 | 2023 | 462 | 0.470 |
Why?
|
| Body Fluids | 2 | 2017 | 70 | 0.470 |
Why?
|
| Cold Temperature | 7 | 2025 | 209 | 0.470 |
Why?
|
| Lung | 12 | 2025 | 4109 | 0.470 |
Why?
|
| Spermidine | 3 | 2024 | 17 | 0.460 |
Why?
|
| Metabolic Flux Analysis | 1 | 2015 | 7 | 0.460 |
Why?
|
| Succinates | 3 | 2025 | 24 | 0.460 |
Why?
|
| Hemorrhage | 5 | 2023 | 809 | 0.460 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2026 | 39 | 0.460 |
Why?
|
| Phenotype | 14 | 2025 | 3162 | 0.460 |
Why?
|
| Cells, Cultured | 20 | 2025 | 4154 | 0.460 |
Why?
|
| Methionine | 4 | 2023 | 162 | 0.450 |
Why?
|
| Acidosis | 1 | 2016 | 105 | 0.450 |
Why?
|
| Acetaminophen | 3 | 2023 | 264 | 0.450 |
Why?
|
| Fibrinolysis | 4 | 2019 | 162 | 0.450 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2022 | 158 | 0.450 |
Why?
|
| Sphingosine | 3 | 2023 | 45 | 0.440 |
Why?
|
| Transcription Factors | 5 | 2025 | 1741 | 0.440 |
Why?
|
| Drosophila | 3 | 2026 | 166 | 0.440 |
Why?
|
| Blood Volume | 1 | 2015 | 65 | 0.440 |
Why?
|
| Interleukin-1beta | 7 | 2025 | 395 | 0.440 |
Why?
|
| Pyruvic Acid | 4 | 2025 | 55 | 0.430 |
Why?
|
| Hemopexin | 2 | 2025 | 38 | 0.430 |
Why?
|
| Genome-Wide Association Study | 5 | 2024 | 1406 | 0.430 |
Why?
|
| Sulfur | 3 | 2022 | 64 | 0.430 |
Why?
|
| Lactoylglutathione Lyase | 2 | 2025 | 19 | 0.430 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 3 | 2021 | 169 | 0.420 |
Why?
|
| Plateletpheresis | 4 | 2024 | 31 | 0.420 |
Why?
|
| Cell Differentiation | 6 | 2024 | 2050 | 0.420 |
Why?
|
| Chromatography, Reverse-Phase | 2 | 2012 | 27 | 0.420 |
Why?
|
| Lactates | 4 | 2023 | 83 | 0.420 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2014 | 3 | 0.420 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 463 | 0.420 |
Why?
|
| Oleic Acid | 2 | 2024 | 42 | 0.420 |
Why?
|
| Hexokinase | 2 | 2024 | 18 | 0.420 |
Why?
|
| Hydrogen-Ion Concentration | 8 | 2024 | 561 | 0.410 |
Why?
|
| Octreotide | 1 | 2014 | 23 | 0.410 |
Why?
|
| PPAR alpha | 3 | 2024 | 54 | 0.410 |
Why?
|
| Substance P | 1 | 2014 | 39 | 0.410 |
Why?
|
| Glutaredoxins | 2 | 2026 | 15 | 0.410 |
Why?
|
| Plant Transpiration | 1 | 2013 | 9 | 0.410 |
Why?
|
| Mustard Plant | 1 | 2013 | 3 | 0.410 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2014 | 143 | 0.400 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 82 | 0.400 |
Why?
|
| Fibrinogen | 4 | 2026 | 177 | 0.400 |
Why?
|
| Protein C | 2 | 2024 | 53 | 0.400 |
Why?
|
| Young Adult | 21 | 2025 | 14105 | 0.400 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 2 | 2024 | 8 | 0.400 |
Why?
|
| Gastrointestinal Microbiome | 5 | 2024 | 771 | 0.390 |
Why?
|
| Reproducibility of Results | 8 | 2026 | 3409 | 0.390 |
Why?
|
| Alcohol Oxidoreductases | 3 | 2025 | 62 | 0.390 |
Why?
|
| Transcriptome | 5 | 2026 | 1045 | 0.390 |
Why?
|
| Glutathione Disulfide | 2 | 2021 | 32 | 0.390 |
Why?
|
| Bacteria | 3 | 2025 | 889 | 0.390 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2025 | 209 | 0.390 |
Why?
|
| Pregnancy | 21 | 2025 | 7190 | 0.390 |
Why?
|
| Postmenopause | 2 | 2026 | 391 | 0.390 |
Why?
|
| Quality Control | 3 | 2022 | 163 | 0.380 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 826 | 0.380 |
Why?
|
| Biomedical Research | 3 | 2021 | 710 | 0.380 |
Why?
|
| Diet | 4 | 2026 | 1273 | 0.380 |
Why?
|
| Triple Negative Breast Neoplasms | 3 | 2024 | 215 | 0.380 |
Why?
|
| Pancreas Transplantation | 11 | 2000 | 69 | 0.380 |
Why?
|
| Photosynthesis | 1 | 2013 | 98 | 0.380 |
Why?
|
| Mevalonic Acid | 2 | 2025 | 12 | 0.380 |
Why?
|
| Hemostatics | 2 | 2023 | 61 | 0.370 |
Why?
|
| Acclimatization | 4 | 2018 | 172 | 0.370 |
Why?
|
| Serpins | 3 | 2022 | 28 | 0.370 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 2 | 2025 | 27 | 0.370 |
Why?
|
| DNA-Binding Proteins | 4 | 2025 | 1499 | 0.370 |
Why?
|
| Fibroblasts | 6 | 2024 | 1034 | 0.370 |
Why?
|
| Homeodomain Proteins | 4 | 2020 | 523 | 0.370 |
Why?
|
| Cell Cycle Proteins | 5 | 2022 | 628 | 0.360 |
Why?
|
| Sex Factors | 5 | 2025 | 2112 | 0.360 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2024 | 108 | 0.360 |
Why?
|
| Chronic Disease | 2 | 2017 | 1813 | 0.360 |
Why?
|
| Fibrin | 2 | 2026 | 91 | 0.360 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2025 | 127 | 0.360 |
Why?
|
| Obesity | 8 | 2025 | 3077 | 0.360 |
Why?
|
| MicroRNAs | 6 | 2018 | 701 | 0.360 |
Why?
|
| Kidney | 9 | 2024 | 1495 | 0.360 |
Why?
|
| Aged | 26 | 2026 | 25913 | 0.360 |
Why?
|
| Aorta | 2 | 2026 | 429 | 0.360 |
Why?
|
| Parenteral Nutrition | 3 | 2021 | 105 | 0.360 |
Why?
|
| Vasoconstrictor Agents | 2 | 2025 | 144 | 0.350 |
Why?
|
| Chromatography, Liquid | 4 | 2019 | 454 | 0.350 |
Why?
|
| Cell Survival | 9 | 2026 | 1098 | 0.350 |
Why?
|
| Blastocyst | 1 | 2011 | 47 | 0.350 |
Why?
|
| Plasticizers | 3 | 2023 | 20 | 0.350 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2026 | 337 | 0.350 |
Why?
|
| Food Safety | 1 | 2011 | 22 | 0.350 |
Why?
|
| Dietary Proteins | 1 | 2012 | 136 | 0.340 |
Why?
|
| Dendritic Cells | 5 | 2024 | 499 | 0.340 |
Why?
|
| Receptors, CCR2 | 2 | 2024 | 39 | 0.340 |
Why?
|
| DNA Methylation | 4 | 2026 | 681 | 0.340 |
Why?
|
| Environmental Pollutants | 1 | 2013 | 167 | 0.340 |
Why?
|
| Sheep | 3 | 2025 | 880 | 0.340 |
Why?
|
| Tryptophan Oxygenase | 4 | 2024 | 33 | 0.340 |
Why?
|
| Erythrocyte Count | 2 | 2021 | 21 | 0.340 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2025 | 147 | 0.340 |
Why?
|
| Gestational Age | 7 | 2024 | 975 | 0.340 |
Why?
|
| Interleukin-1 | 3 | 2021 | 961 | 0.340 |
Why?
|
| Brain | 10 | 2024 | 2933 | 0.340 |
Why?
|
| Metformin | 2 | 2025 | 318 | 0.340 |
Why?
|
| Retina | 1 | 2014 | 324 | 0.340 |
Why?
|
| Glycocalyx | 2 | 2025 | 30 | 0.340 |
Why?
|
| Reactive Nitrogen Species | 1 | 2011 | 16 | 0.340 |
Why?
|
| Mitochondrial Proteins | 3 | 2025 | 262 | 0.340 |
Why?
|
| Adipose Tissue | 4 | 2025 | 652 | 0.330 |
Why?
|
| Enzyme Activation | 5 | 2024 | 766 | 0.330 |
Why?
|
| Critical Illness | 1 | 2017 | 891 | 0.330 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 197 | 0.330 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2020 | 428 | 0.330 |
Why?
|
| Docosahexaenoic Acids | 1 | 2011 | 83 | 0.330 |
Why?
|
| Lung Diseases | 1 | 2017 | 787 | 0.330 |
Why?
|
| Transplantation, Autologous | 3 | 2023 | 290 | 0.330 |
Why?
|
| Anemia | 2 | 2023 | 188 | 0.320 |
Why?
|
| Diet, Western | 4 | 2025 | 86 | 0.320 |
Why?
|
| Isoenzymes | 2 | 2024 | 299 | 0.320 |
Why?
|
| Food | 1 | 2011 | 149 | 0.320 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2009 | 230 | 0.320 |
Why?
|
| Histones | 4 | 2025 | 669 | 0.320 |
Why?
|
| Kidney Failure, Chronic | 6 | 2016 | 598 | 0.320 |
Why?
|
| Medicine | 1 | 2012 | 125 | 0.320 |
Why?
|
| NF-kappa B | 5 | 2021 | 661 | 0.320 |
Why?
|
| Lipid Peroxidation | 2 | 2025 | 160 | 0.320 |
Why?
|
| Egg Proteins | 1 | 2010 | 20 | 0.310 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 138 | 0.310 |
Why?
|
| Urinary Diversion | 1 | 2009 | 13 | 0.310 |
Why?
|
| Proteolysis | 4 | 2020 | 173 | 0.310 |
Why?
|
| Cell Respiration | 8 | 2025 | 107 | 0.310 |
Why?
|
| Nitric Oxide | 4 | 2022 | 897 | 0.310 |
Why?
|
| Pyruvates | 4 | 2023 | 24 | 0.310 |
Why?
|
| Flavones | 2 | 2019 | 11 | 0.310 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 2583 | 0.300 |
Why?
|
| Epigenesis, Genetic | 4 | 2024 | 684 | 0.300 |
Why?
|
| Folic Acid | 2 | 2024 | 199 | 0.300 |
Why?
|
| RNA Polymerase II | 2 | 2026 | 351 | 0.300 |
Why?
|
| Tissue Plasminogen Activator | 4 | 2023 | 244 | 0.300 |
Why?
|
| Sepsis | 2 | 2026 | 640 | 0.300 |
Why?
|
| Pharmacogenetics | 1 | 2010 | 172 | 0.300 |
Why?
|
| Superoxide Dismutase | 1 | 2011 | 301 | 0.300 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 3 | 2024 | 55 | 0.290 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 2 | 2026 | 46 | 0.290 |
Why?
|
| Longitudinal Studies | 4 | 2026 | 2947 | 0.290 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 2 | 2020 | 20 | 0.290 |
Why?
|
| Neutrophils | 6 | 2022 | 1134 | 0.290 |
Why?
|
| Tissue and Organ Procurement | 5 | 2016 | 346 | 0.290 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2025 | 905 | 0.280 |
Why?
|
| Vasodilation | 2 | 2025 | 523 | 0.280 |
Why?
|
| RNA Splicing Factors | 2 | 2026 | 64 | 0.280 |
Why?
|
| Fetus | 4 | 2020 | 803 | 0.280 |
Why?
|
| Platelet Function Tests | 2 | 2020 | 34 | 0.280 |
Why?
|
| Alanine Transaminase | 4 | 2023 | 151 | 0.280 |
Why?
|
| Membrane Proteins | 4 | 2025 | 1166 | 0.280 |
Why?
|
| Pilot Projects | 6 | 2025 | 1886 | 0.280 |
Why?
|
| Xenograft Model Antitumor Assays | 8 | 2026 | 928 | 0.280 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 2 | 2024 | 13 | 0.280 |
Why?
|
| Milk, Human | 1 | 2010 | 172 | 0.280 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2025 | 969 | 0.270 |
Why?
|
| Graft Rejection | 11 | 2016 | 540 | 0.270 |
Why?
|
| Nitriles | 2 | 2020 | 205 | 0.270 |
Why?
|
| Tumor Microenvironment | 6 | 2024 | 732 | 0.270 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2025 | 1953 | 0.270 |
Why?
|
| Glucose Transporter Type 1 | 2 | 2026 | 48 | 0.270 |
Why?
|
| Prospective Studies | 9 | 2025 | 7990 | 0.270 |
Why?
|
| Up-Regulation | 4 | 2024 | 851 | 0.270 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2021 | 276 | 0.270 |
Why?
|
| Inflammasomes | 2 | 2020 | 146 | 0.270 |
Why?
|
| Models, Molecular | 4 | 2021 | 1618 | 0.270 |
Why?
|
| Tandem Mass Spectrometry | 5 | 2024 | 576 | 0.270 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 2 | 2017 | 18 | 0.270 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 2 | 2017 | 17 | 0.270 |
Why?
|
| Sex Characteristics | 6 | 2023 | 790 | 0.270 |
Why?
|
| Nitrogen Isotopes | 2 | 2017 | 72 | 0.270 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2025 | 1217 | 0.260 |
Why?
|
| Double-Blind Method | 4 | 2025 | 2029 | 0.260 |
Why?
|
| Transglutaminases | 2 | 2026 | 159 | 0.260 |
Why?
|
| Muscles | 2 | 2026 | 333 | 0.260 |
Why?
|
| Cardiovascular Diseases | 3 | 2026 | 2168 | 0.260 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 192 | 0.260 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2018 | 69 | 0.260 |
Why?
|
| Lymph Nodes | 2 | 2024 | 502 | 0.260 |
Why?
|
| Melanoma, Experimental | 3 | 2024 | 108 | 0.260 |
Why?
|
| Lymphatic Vessels | 2 | 2020 | 63 | 0.260 |
Why?
|
| Macrophages, Alveolar | 2 | 2021 | 368 | 0.260 |
Why?
|
| Solute Carrier Family 22 Member 5 | 2 | 2024 | 7 | 0.260 |
Why?
|
| Reticulocytes | 2 | 2024 | 17 | 0.260 |
Why?
|
| Pulmonary Artery | 5 | 2025 | 1134 | 0.260 |
Why?
|
| Cell Line | 10 | 2023 | 2882 | 0.260 |
Why?
|
| Heme | 2 | 2025 | 89 | 0.260 |
Why?
|
| Erythropoiesis | 5 | 2025 | 57 | 0.260 |
Why?
|
| Thrombelastography | 3 | 2023 | 178 | 0.250 |
Why?
|
| Saline Solution, Hypertonic | 2 | 2017 | 42 | 0.250 |
Why?
|
| Melanoma | 2 | 2024 | 761 | 0.250 |
Why?
|
| Graft Survival | 16 | 2016 | 526 | 0.250 |
Why?
|
| Maternal Exposure | 2 | 2019 | 213 | 0.250 |
Why?
|
| Machine Learning | 5 | 2026 | 585 | 0.250 |
Why?
|
| Hypertension | 4 | 2021 | 1263 | 0.250 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2017 | 49 | 0.250 |
Why?
|
| Spleen | 3 | 2025 | 508 | 0.250 |
Why?
|
| Larva | 6 | 2025 | 242 | 0.250 |
Why?
|
| Phthalic Acids | 2 | 2024 | 51 | 0.250 |
Why?
|
| Hyperaldosteronism | 2 | 2019 | 12 | 0.250 |
Why?
|
| Case-Control Studies | 8 | 2024 | 3604 | 0.250 |
Why?
|
| Genomics | 1 | 2012 | 834 | 0.250 |
Why?
|
| Interferons | 3 | 2023 | 188 | 0.240 |
Why?
|
| Fructose | 2 | 2026 | 130 | 0.240 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2026 | 22 | 0.240 |
Why?
|
| Placenta | 2 | 2025 | 780 | 0.240 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2016 | 56 | 0.240 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2026 | 18 | 0.240 |
Why?
|
| Familial Primary Pulmonary Hypertension | 2 | 2017 | 197 | 0.240 |
Why?
|
| Organ Preservation | 9 | 1999 | 130 | 0.240 |
Why?
|
| Blood Safety | 3 | 2017 | 11 | 0.240 |
Why?
|
| Isoantigens | 1 | 2025 | 17 | 0.240 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2026 | 85 | 0.240 |
Why?
|
| Lauric Acids | 1 | 2026 | 9 | 0.240 |
Why?
|
| Microglia | 3 | 2023 | 268 | 0.240 |
Why?
|
| Dietary Sugars | 1 | 2026 | 16 | 0.240 |
Why?
|
| Solutions | 4 | 2018 | 166 | 0.240 |
Why?
|
| Anaerobiosis | 4 | 2017 | 64 | 0.240 |
Why?
|
| Wolbachia | 1 | 2025 | 3 | 0.240 |
Why?
|
| Serine | 2 | 2025 | 145 | 0.230 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2021 | 219 | 0.230 |
Why?
|
| Chondroitin Sulfates | 1 | 2026 | 35 | 0.230 |
Why?
|
| Dietary Supplements | 5 | 2026 | 576 | 0.230 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2021 | 474 | 0.230 |
Why?
|
| Xylitol | 1 | 2025 | 4 | 0.230 |
Why?
|
| Cholangitis | 1 | 2026 | 23 | 0.230 |
Why?
|
| Erythritol | 1 | 2025 | 2 | 0.230 |
Why?
|
| Isotonic Solutions | 2 | 2016 | 39 | 0.230 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2025 | 4 | 0.230 |
Why?
|
| Insulin Resistance | 3 | 2021 | 1241 | 0.230 |
Why?
|
| Electron Transport Complex II | 3 | 2022 | 28 | 0.230 |
Why?
|
| Lipoproteins | 3 | 2021 | 169 | 0.230 |
Why?
|
| Hydrogen Peroxide | 3 | 2025 | 336 | 0.230 |
Why?
|
| Urea | 3 | 2023 | 84 | 0.230 |
Why?
|
| Sound | 1 | 2026 | 55 | 0.230 |
Why?
|
| Connexin 43 | 1 | 2025 | 36 | 0.230 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 2025 | 5 | 0.230 |
Why?
|
| Qa-SNARE Proteins | 1 | 2025 | 19 | 0.230 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2025 | 15 | 0.230 |
Why?
|
| Nanoparticles | 2 | 2022 | 519 | 0.230 |
Why?
|
| Cell Hypoxia | 3 | 2022 | 247 | 0.230 |
Why?
|
| Antimalarials | 2 | 2024 | 35 | 0.230 |
Why?
|
| Cell Self Renewal | 3 | 2021 | 53 | 0.230 |
Why?
|
| In Vitro Techniques | 4 | 2021 | 1047 | 0.230 |
Why?
|
| Neuroacanthocytosis | 1 | 2025 | 5 | 0.230 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2025 | 6 | 0.230 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2025 | 20 | 0.220 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2022 | 851 | 0.220 |
Why?
|
| Mice, Inbred NOD | 7 | 2021 | 610 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2024 | 2145 | 0.220 |
Why?
|
| Interleukin-2 | 2 | 2023 | 437 | 0.220 |
Why?
|
| Aging, Premature | 1 | 2025 | 16 | 0.220 |
Why?
|
| Thiolester Hydrolases | 1 | 2025 | 13 | 0.220 |
Why?
|
| Liver Cirrhosis | 2 | 2025 | 288 | 0.220 |
Why?
|
| GTP-Binding Proteins | 1 | 2026 | 153 | 0.220 |
Why?
|
| Muscular Diseases | 1 | 2025 | 108 | 0.220 |
Why?
|
| Haptoglobins | 1 | 2025 | 66 | 0.220 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2025 | 115 | 0.220 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 7 | 2015 | 110 | 0.220 |
Why?
|
| Syndecan-1 | 2 | 2025 | 42 | 0.220 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2025 | 16 | 0.220 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2026 | 89 | 0.220 |
Why?
|
| Cation Transport Proteins | 1 | 2026 | 118 | 0.220 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2025 | 37 | 0.220 |
Why?
|
| Sweetening Agents | 1 | 2025 | 57 | 0.220 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2016 | 112 | 0.220 |
Why?
|
| Cognitive Dysfunction | 2 | 2021 | 461 | 0.220 |
Why?
|
| Horses | 2 | 2024 | 201 | 0.220 |
Why?
|
| Astrocytes | 2 | 2024 | 222 | 0.220 |
Why?
|
| Gene Expression | 5 | 2022 | 1490 | 0.220 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2025 | 253 | 0.220 |
Why?
|
| Primaquine | 1 | 2024 | 7 | 0.220 |
Why?
|
| Biological Transport | 3 | 2018 | 417 | 0.220 |
Why?
|
| Alleles | 2 | 2025 | 879 | 0.220 |
Why?
|
| Symbiosis | 1 | 2025 | 81 | 0.220 |
Why?
|
| Mucosal-Associated Invariant T Cells | 1 | 2025 | 37 | 0.220 |
Why?
|
| Random Allocation | 2 | 2023 | 363 | 0.220 |
Why?
|
| GTP Phosphohydrolases | 1 | 2025 | 93 | 0.220 |
Why?
|
| Enzyme Activators | 1 | 2024 | 9 | 0.220 |
Why?
|
| Gene Expression Profiling | 8 | 2021 | 1782 | 0.220 |
Why?
|
| Reference Standards | 2 | 2017 | 177 | 0.220 |
Why?
|
| Down-Regulation | 2 | 2025 | 627 | 0.220 |
Why?
|
| Phosphofructokinases | 1 | 2024 | 7 | 0.220 |
Why?
|
| Neoplasm Invasiveness | 2 | 2024 | 508 | 0.210 |
Why?
|
| Dogs | 2 | 2024 | 437 | 0.210 |
Why?
|
| Inflammation Mediators | 4 | 2021 | 509 | 0.210 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2024 | 2 | 0.210 |
Why?
|
| Aspartate-Ammonia Ligase | 1 | 2024 | 2 | 0.210 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2023 | 98 | 0.210 |
Why?
|
| Cachexia | 1 | 2025 | 75 | 0.210 |
Why?
|
| Vesicular Transport Proteins | 1 | 2025 | 86 | 0.210 |
Why?
|
| Spheroids, Cellular | 1 | 2025 | 73 | 0.210 |
Why?
|
| Connective Tissue Diseases | 1 | 2025 | 84 | 0.210 |
Why?
|
| RNA | 2 | 2023 | 940 | 0.210 |
Why?
|
| Listeriosis | 2 | 2021 | 65 | 0.210 |
Why?
|
| Lysine | 4 | 2019 | 302 | 0.210 |
Why?
|
| Mitochondria, Muscle | 4 | 2021 | 121 | 0.210 |
Why?
|
| Thrombocythemia, Essential | 1 | 2024 | 6 | 0.210 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2024 | 109 | 0.210 |
Why?
|
| Copper | 1 | 2025 | 113 | 0.210 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2023 | 118 | 0.210 |
Why?
|
| Phosphoproteins | 3 | 2023 | 344 | 0.210 |
Why?
|
| Herpesviridae Infections | 1 | 2025 | 150 | 0.210 |
Why?
|
| Bleomycin | 1 | 2025 | 253 | 0.210 |
Why?
|
| Infant, Newborn | 11 | 2024 | 6429 | 0.210 |
Why?
|
| Microbiota | 2 | 2025 | 781 | 0.210 |
Why?
|
| Proline | 1 | 2024 | 83 | 0.210 |
Why?
|
| Myeloproliferative Disorders | 1 | 2024 | 19 | 0.210 |
Why?
|
| Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 17 | 0.210 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 3 | 2021 | 131 | 0.200 |
Why?
|
| Chemokine CCL2 | 1 | 2024 | 115 | 0.200 |
Why?
|
| Interleukin-7 | 1 | 2024 | 65 | 0.200 |
Why?
|
| Hydroxyurea | 1 | 2023 | 34 | 0.200 |
Why?
|
| Calcium Signaling | 2 | 2023 | 251 | 0.200 |
Why?
|
| Amino Acid Sequence | 4 | 2019 | 2155 | 0.200 |
Why?
|
| DNA, Mitochondrial | 1 | 2025 | 211 | 0.200 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2023 | 24 | 0.200 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2022 | 269 | 0.200 |
Why?
|
| Immunoglobulin G | 2 | 2026 | 893 | 0.200 |
Why?
|
| Myeloid Cells | 2 | 2024 | 148 | 0.200 |
Why?
|
| Microchip Analytical Procedures | 1 | 2023 | 5 | 0.200 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 865 | 0.200 |
Why?
|
| Dietary Fats | 1 | 2026 | 314 | 0.200 |
Why?
|
| Regeneration | 1 | 2025 | 197 | 0.200 |
Why?
|
| Listeria monocytogenes | 2 | 2021 | 116 | 0.200 |
Why?
|
| C-Reactive Protein | 3 | 2022 | 416 | 0.200 |
Why?
|
| AMP Deaminase | 1 | 2023 | 11 | 0.200 |
Why?
|
| NADP | 4 | 2021 | 55 | 0.200 |
Why?
|
| Uterine Artery | 1 | 2024 | 75 | 0.200 |
Why?
|
| Limb Buds | 1 | 2023 | 23 | 0.200 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2023 | 28 | 0.200 |
Why?
|
| Hyperglycemia | 2 | 2025 | 375 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2019 | 240 | 0.200 |
Why?
|
| Introns | 1 | 2024 | 254 | 0.200 |
Why?
|
| Osmotic Pressure | 2 | 2020 | 39 | 0.200 |
Why?
|
| Computational Biology | 3 | 2014 | 680 | 0.200 |
Why?
|
| Infant Behavior | 2 | 2020 | 26 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 1455 | 0.200 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2024 | 71 | 0.200 |
Why?
|
| Africa South of the Sahara | 1 | 2023 | 53 | 0.200 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2025 | 95 | 0.200 |
Why?
|
| Pteridines | 1 | 2023 | 22 | 0.200 |
Why?
|
| Down Syndrome | 2 | 2021 | 534 | 0.200 |
Why?
|
| Capillary Permeability | 1 | 2023 | 134 | 0.200 |
Why?
|
| Protein Kinase C-delta | 1 | 2023 | 46 | 0.200 |
Why?
|
| Pre-Eclampsia | 1 | 2025 | 204 | 0.200 |
Why?
|
| Hepatocytes | 5 | 2026 | 223 | 0.200 |
Why?
|
| Giant Cell Arteritis | 1 | 2023 | 46 | 0.190 |
Why?
|
| Macrophage Activation | 2 | 2021 | 193 | 0.190 |
Why?
|
| Phagocytosis | 1 | 2025 | 299 | 0.190 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2024 | 164 | 0.190 |
Why?
|
| Vinblastine | 1 | 2023 | 75 | 0.190 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2022 | 259 | 0.190 |
Why?
|
| Streptococcus pneumoniae | 1 | 2025 | 177 | 0.190 |
Why?
|
| RNA Splicing | 2 | 2026 | 284 | 0.190 |
Why?
|
| DNA Modification Methylases | 1 | 2022 | 18 | 0.190 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2023 | 103 | 0.190 |
Why?
|
| Epithelial Cells | 3 | 2021 | 1125 | 0.190 |
Why?
|
| Diet, High-Fat | 5 | 2024 | 261 | 0.190 |
Why?
|
| Radiation Tolerance | 1 | 2023 | 103 | 0.190 |
Why?
|
| Blood-Brain Barrier | 1 | 2024 | 155 | 0.190 |
Why?
|
| Sirtuin 3 | 1 | 2023 | 60 | 0.190 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2024 | 180 | 0.190 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2017 | 331 | 0.190 |
Why?
|
| Thrombophilia | 1 | 2023 | 88 | 0.190 |
Why?
|
| Glutamic Acid | 3 | 2017 | 251 | 0.190 |
Why?
|
| Carbon Dioxide | 2 | 2015 | 242 | 0.190 |
Why?
|
| Spectrin | 1 | 2022 | 14 | 0.190 |
Why?
|
| Imines | 1 | 2022 | 6 | 0.190 |
Why?
|
| src-Family Kinases | 1 | 2023 | 93 | 0.190 |
Why?
|
| Stress, Mechanical | 1 | 2024 | 494 | 0.190 |
Why?
|
| Aldehydes | 1 | 2023 | 142 | 0.180 |
Why?
|
| Valosin Containing Protein | 1 | 2022 | 8 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2022 | 167 | 0.180 |
Why?
|
| Antigens | 1 | 2024 | 347 | 0.180 |
Why?
|
| Cell Communication | 1 | 2024 | 324 | 0.180 |
Why?
|
| Histiocytosis | 1 | 2022 | 9 | 0.180 |
Why?
|
| Complement C4 | 1 | 2022 | 26 | 0.180 |
Why?
|
| Multiple Myeloma | 2 | 2023 | 291 | 0.180 |
Why?
|
| Mice, SCID | 5 | 2021 | 369 | 0.180 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2025 | 234 | 0.180 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2026 | 419 | 0.180 |
Why?
|
| Bicycling | 1 | 2023 | 120 | 0.180 |
Why?
|
| Cytophagocytosis | 1 | 2022 | 4 | 0.180 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 192 | 0.180 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2022 | 12 | 0.180 |
Why?
|
| Insulin | 10 | 2021 | 2507 | 0.180 |
Why?
|
| Benzoquinones | 1 | 2022 | 47 | 0.180 |
Why?
|
| Coagulants | 2 | 2012 | 20 | 0.180 |
Why?
|
| Erdheim-Chester Disease | 1 | 2021 | 4 | 0.180 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2022 | 109 | 0.180 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2021 | 266 | 0.180 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2021 | 10 | 0.180 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2024 | 221 | 0.180 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2022 | 31 | 0.180 |
Why?
|
| Child Development | 3 | 2024 | 484 | 0.180 |
Why?
|
| Antibodies, Viral | 2 | 2026 | 672 | 0.180 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2022 | 47 | 0.180 |
Why?
|
| Blast Injuries | 1 | 2022 | 63 | 0.180 |
Why?
|
| Biogenic Amines | 1 | 2021 | 4 | 0.180 |
Why?
|
| Pulmonary Fibrosis | 1 | 2025 | 395 | 0.180 |
Why?
|
| Glioblastoma | 2 | 2022 | 353 | 0.180 |
Why?
|
| Escherichia coli Proteins | 1 | 2023 | 206 | 0.170 |
Why?
|
| Blood | 1 | 2022 | 109 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 2363 | 0.170 |
Why?
|
| Isoxazoles | 1 | 2021 | 53 | 0.170 |
Why?
|
| Persea | 1 | 2021 | 1 | 0.170 |
Why?
|
| Aurora Kinase B | 1 | 2021 | 11 | 0.170 |
Why?
|
| Phytosterols | 1 | 2021 | 12 | 0.170 |
Why?
|
| Nervous System Malformations | 1 | 2022 | 47 | 0.170 |
Why?
|
| Polyketides | 1 | 2021 | 5 | 0.170 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2026 | 579 | 0.170 |
Why?
|
| Breathing Exercises | 1 | 2021 | 21 | 0.170 |
Why?
|
| Gene Regulatory Networks | 4 | 2014 | 318 | 0.170 |
Why?
|
| Primates | 2 | 2023 | 132 | 0.170 |
Why?
|
| Malaria, Falciparum | 1 | 2021 | 33 | 0.170 |
Why?
|
| Dermatitis, Atopic | 1 | 2025 | 321 | 0.170 |
Why?
|
| Lipid Bilayers | 1 | 2022 | 103 | 0.170 |
Why?
|
| Recombinant Proteins | 2 | 2022 | 1370 | 0.170 |
Why?
|
| Carrier Proteins | 2 | 2025 | 737 | 0.170 |
Why?
|
| Inhalation | 1 | 2021 | 29 | 0.170 |
Why?
|
| RNA, Viral | 2 | 2023 | 688 | 0.170 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 2 | 2025 | 181 | 0.170 |
Why?
|
| Gene Knock-In Techniques | 1 | 2021 | 61 | 0.170 |
Why?
|
| Respiratory Muscles | 1 | 2021 | 36 | 0.170 |
Why?
|
| Thyroid Hormones | 1 | 2021 | 67 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2026 | 365 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2026 | 339 | 0.170 |
Why?
|
| Cyst Fluid | 1 | 2021 | 20 | 0.170 |
Why?
|
| Cohort Studies | 6 | 2023 | 5960 | 0.170 |
Why?
|
| Factor VIII | 2 | 2012 | 104 | 0.170 |
Why?
|
| Biological Products | 2 | 2022 | 252 | 0.170 |
Why?
|
| Myelopoiesis | 1 | 2021 | 10 | 0.170 |
Why?
|
| Sphingolipids | 2 | 2021 | 83 | 0.170 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 2930 | 0.170 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2021 | 452 | 0.170 |
Why?
|
| Auditory Pathways | 1 | 2021 | 53 | 0.170 |
Why?
|
| Methylation | 2 | 2018 | 242 | 0.170 |
Why?
|
| Injury Severity Score | 5 | 2025 | 600 | 0.170 |
Why?
|
| Cell Tracking | 1 | 2021 | 19 | 0.170 |
Why?
|
| Cell Lineage | 4 | 2026 | 376 | 0.170 |
Why?
|
| Asthma | 2 | 2024 | 1767 | 0.170 |
Why?
|
| Lung Neoplasms | 3 | 2025 | 2637 | 0.170 |
Why?
|
| Erythrocyte Indices | 3 | 2018 | 33 | 0.170 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2020 | 8 | 0.170 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2022 | 123 | 0.170 |
Why?
|
| Athletes | 2 | 2022 | 419 | 0.170 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 142 | 0.170 |
Why?
|
| Maneb | 1 | 2020 | 9 | 0.170 |
Why?
|
| Blood Pressure | 3 | 2026 | 1769 | 0.170 |
Why?
|
| Gelsolin | 2 | 2014 | 10 | 0.170 |
Why?
|
| Sodium Nitrite | 1 | 2021 | 39 | 0.160 |
Why?
|
| Seroconversion | 1 | 2021 | 49 | 0.160 |
Why?
|
| Virulence Factors | 1 | 2022 | 172 | 0.160 |
Why?
|
| Cadaver | 8 | 2009 | 304 | 0.160 |
Why?
|
| Vascular Stiffness | 1 | 2026 | 486 | 0.160 |
Why?
|
| Resistance Training | 1 | 2023 | 182 | 0.160 |
Why?
|
| Azacitidine | 2 | 2018 | 156 | 0.160 |
Why?
|
| Immunoglobulin M | 1 | 2022 | 284 | 0.160 |
Why?
|
| Cystine | 1 | 2020 | 18 | 0.160 |
Why?
|
| Benzothiazoles | 2 | 2017 | 40 | 0.160 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 241 | 0.160 |
Why?
|
| Least-Squares Analysis | 2 | 2021 | 76 | 0.160 |
Why?
|
| Cell Plasticity | 1 | 2021 | 37 | 0.160 |
Why?
|
| Aniline Compounds | 1 | 2021 | 119 | 0.160 |
Why?
|
| Membrane Transport Proteins | 2 | 2023 | 154 | 0.160 |
Why?
|
| Pyrazines | 1 | 2021 | 92 | 0.160 |
Why?
|
| Staining and Labeling | 1 | 2021 | 151 | 0.160 |
Why?
|
| Ammonia | 1 | 2020 | 65 | 0.160 |
Why?
|
| Protein Unfolding | 1 | 2020 | 33 | 0.160 |
Why?
|
| Organ Transplantation | 4 | 2007 | 247 | 0.160 |
Why?
|
| Electron Transport Chain Complex Proteins | 2 | 2019 | 20 | 0.160 |
Why?
|
| Nonprescription Drugs | 1 | 2021 | 65 | 0.160 |
Why?
|
| Kidney Neoplasms | 1 | 2025 | 412 | 0.160 |
Why?
|
| Antigens, Neoplasm | 2 | 2014 | 271 | 0.160 |
Why?
|
| Cellular Microenvironment | 1 | 2021 | 94 | 0.160 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2020 | 66 | 0.160 |
Why?
|
| Cell Nucleus | 3 | 2018 | 618 | 0.160 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 111 | 0.160 |
Why?
|
| Preoperative Period | 2 | 2019 | 149 | 0.160 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 130 | 0.160 |
Why?
|
| B-Lymphocytes | 1 | 2025 | 876 | 0.160 |
Why?
|
| Creatine | 1 | 2020 | 63 | 0.160 |
Why?
|
| Lipase | 1 | 2020 | 75 | 0.160 |
Why?
|
| Databases, Genetic | 1 | 2021 | 248 | 0.160 |
Why?
|
| Lipoproteins, LDL | 1 | 2020 | 119 | 0.160 |
Why?
|
| Thrombin | 4 | 2023 | 166 | 0.160 |
Why?
|
| Extracellular Matrix | 3 | 2025 | 553 | 0.160 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2021 | 72 | 0.160 |
Why?
|
| Antigens, CD34 | 2 | 2010 | 88 | 0.160 |
Why?
|
| Cannabidiol | 1 | 2022 | 136 | 0.160 |
Why?
|
| Phosphatidylserines | 1 | 2020 | 60 | 0.150 |
Why?
|
| TCF Transcription Factors | 1 | 2019 | 19 | 0.150 |
Why?
|
| Neutropenia | 1 | 2020 | 155 | 0.150 |
Why?
|
| Cannabinoids | 1 | 2022 | 182 | 0.150 |
Why?
|
| Skin | 1 | 2025 | 755 | 0.150 |
Why?
|
| Phenylurea Compounds | 2 | 2017 | 112 | 0.150 |
Why?
|
| Superoxides | 2 | 2017 | 204 | 0.150 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2019 | 26 | 0.150 |
Why?
|
| Lisinopril | 1 | 2019 | 15 | 0.150 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 2019 | 19 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2020 | 66 | 0.150 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 145 | 0.150 |
Why?
|
| Iron Overload | 1 | 2019 | 19 | 0.150 |
Why?
|
| Iron, Dietary | 1 | 2019 | 23 | 0.150 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2021 | 225 | 0.150 |
Why?
|
| Vascular Remodeling | 4 | 2024 | 205 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2019 | 42 | 0.150 |
Why?
|
| Hyperinsulinism | 1 | 2020 | 113 | 0.150 |
Why?
|
| Chromium Radioisotopes | 1 | 2019 | 4 | 0.150 |
Why?
|
| Shock | 1 | 2020 | 108 | 0.150 |
Why?
|
| Trauma Centers | 2 | 2024 | 462 | 0.150 |
Why?
|
| Factor XIIIa | 1 | 2019 | 6 | 0.150 |
Why?
|
| Receptors, Interferon | 1 | 2019 | 60 | 0.150 |
Why?
|
| Sirtuins | 1 | 2019 | 50 | 0.150 |
Why?
|
| Prescription Drugs | 1 | 2021 | 111 | 0.150 |
Why?
|
| Cell Membrane | 2 | 2022 | 706 | 0.150 |
Why?
|
| Neurons | 5 | 2024 | 1640 | 0.150 |
Why?
|
| Leukopoiesis | 1 | 2019 | 11 | 0.150 |
Why?
|
| Sensory Gating | 1 | 2019 | 44 | 0.150 |
Why?
|
| HEK293 Cells | 5 | 2021 | 744 | 0.150 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2018 | 72 | 0.150 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2019 | 17 | 0.150 |
Why?
|
| NADPH Oxidase 2 | 1 | 2019 | 35 | 0.150 |
Why?
|
| Essential Hypertension | 1 | 2019 | 2 | 0.150 |
Why?
|
| Peptide Mapping | 1 | 2019 | 63 | 0.150 |
Why?
|
| Indoles | 4 | 2026 | 501 | 0.150 |
Why?
|
| Feces | 2 | 2019 | 513 | 0.150 |
Why?
|
| Body Mass Index | 3 | 2025 | 2438 | 0.150 |
Why?
|
| Pharmaceutical Solutions | 1 | 2019 | 14 | 0.150 |
Why?
|
| Motor Activity | 1 | 2024 | 721 | 0.150 |
Why?
|
| Macaca mulatta | 1 | 2019 | 191 | 0.150 |
Why?
|
| Escherichia coli | 1 | 2023 | 854 | 0.150 |
Why?
|
| Phosphorylation | 6 | 2025 | 1732 | 0.150 |
Why?
|
| Thyroid Neoplasms | 1 | 2023 | 345 | 0.150 |
Why?
|
| Creatinine | 2 | 2020 | 506 | 0.140 |
Why?
|
| RNA Cleavage | 1 | 2018 | 10 | 0.140 |
Why?
|
| Oxidoreductases | 1 | 2019 | 96 | 0.140 |
Why?
|
| Circadian Clocks | 1 | 2019 | 59 | 0.140 |
Why?
|
| RNA Interference | 5 | 2020 | 476 | 0.140 |
Why?
|
| Heart Failure, Diastolic | 1 | 2019 | 24 | 0.140 |
Why?
|
| Cardio-Renal Syndrome | 1 | 2019 | 18 | 0.140 |
Why?
|
| RNA, Messenger | 4 | 2022 | 2832 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2020 | 167 | 0.140 |
Why?
|
| Hallucinogens | 1 | 2021 | 108 | 0.140 |
Why?
|
| Trisomy | 1 | 2019 | 78 | 0.140 |
Why?
|
| Click Chemistry | 1 | 2019 | 51 | 0.140 |
Why?
|
| Oxidants | 1 | 2019 | 103 | 0.140 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2018 | 24 | 0.140 |
Why?
|
| Radiosurgery | 1 | 2022 | 400 | 0.140 |
Why?
|
| RNA Precursors | 1 | 2020 | 156 | 0.140 |
Why?
|
| Cigarette Smoking | 1 | 2020 | 99 | 0.140 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2025 | 985 | 0.140 |
Why?
|
| Transcription Termination, Genetic | 1 | 2018 | 23 | 0.140 |
Why?
|
| Gene-Environment Interaction | 1 | 2020 | 180 | 0.140 |
Why?
|
| Lipopolysaccharides | 5 | 2021 | 863 | 0.140 |
Why?
|
| Treatment Outcome | 10 | 2024 | 11679 | 0.140 |
Why?
|
| Infant | 9 | 2024 | 10034 | 0.140 |
Why?
|
| Disease Progression | 5 | 2025 | 2847 | 0.140 |
Why?
|
| Coenzymes | 1 | 2018 | 19 | 0.140 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2018 | 15 | 0.140 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2018 | 27 | 0.140 |
Why?
|
| Acute Disease | 1 | 2021 | 1030 | 0.140 |
Why?
|
| Papillomavirus Infections | 1 | 2022 | 345 | 0.140 |
Why?
|
| Vaccines, Subunit | 1 | 2018 | 53 | 0.140 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 375 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2018 | 630 | 0.140 |
Why?
|
| Therapeutics | 1 | 2018 | 13 | 0.140 |
Why?
|
| Pyrroles | 3 | 2026 | 217 | 0.140 |
Why?
|
| Placental Insufficiency | 1 | 2019 | 125 | 0.140 |
Why?
|
| Diagnosis | 1 | 2018 | 16 | 0.140 |
Why?
|
| Deamination | 1 | 2017 | 6 | 0.140 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2018 | 38 | 0.140 |
Why?
|
| Age Factors | 3 | 2024 | 3333 | 0.140 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2018 | 81 | 0.140 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2017 | 14 | 0.130 |
Why?
|
| Hemoglobin A | 1 | 2017 | 21 | 0.130 |
Why?
|
| Vascular Diseases | 1 | 2020 | 251 | 0.130 |
Why?
|
| Hydroxylamine | 1 | 2017 | 7 | 0.130 |
Why?
|
| Analysis of Variance | 2 | 2018 | 1306 | 0.130 |
Why?
|
| Benzeneacetamides | 1 | 2017 | 8 | 0.130 |
Why?
|
| Diglycerides | 1 | 2018 | 59 | 0.130 |
Why?
|
| Liquid-Liquid Extraction | 1 | 2017 | 14 | 0.130 |
Why?
|
| Glutaminase | 1 | 2017 | 11 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 675 | 0.130 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 85 | 0.130 |
Why?
|
| Crush Injuries | 1 | 2017 | 12 | 0.130 |
Why?
|
| Glycogen | 1 | 2017 | 54 | 0.130 |
Why?
|
| Genetic Variation | 2 | 2020 | 983 | 0.130 |
Why?
|
| Freezing | 1 | 2017 | 86 | 0.130 |
Why?
|
| Vitreous Body | 1 | 2018 | 117 | 0.130 |
Why?
|
| Linear Models | 2 | 2017 | 854 | 0.130 |
Why?
|
| ABO Blood-Group System | 2 | 2024 | 57 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 1539 | 0.130 |
Why?
|
| Cluster Analysis | 2 | 2016 | 521 | 0.130 |
Why?
|
| Retinal Detachment | 1 | 2018 | 72 | 0.130 |
Why?
|
| Thiadiazoles | 1 | 2017 | 27 | 0.130 |
Why?
|
| Swine, Miniature | 1 | 2017 | 89 | 0.130 |
Why?
|
| Nicotine | 1 | 2020 | 331 | 0.130 |
Why?
|
| Folic Acid Deficiency | 1 | 2017 | 49 | 0.130 |
Why?
|
| Immune System | 1 | 2018 | 179 | 0.130 |
Why?
|
| Premature Birth | 1 | 2021 | 380 | 0.130 |
Why?
|
| Endovascular Procedures | 1 | 2022 | 384 | 0.130 |
Why?
|
| Cystathionine | 1 | 2016 | 22 | 0.130 |
Why?
|
| Acute Lung Injury | 2 | 2017 | 303 | 0.130 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 354 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 459 | 0.130 |
Why?
|
| Limit of Detection | 1 | 2017 | 97 | 0.130 |
Why?
|
| Basigin | 1 | 2017 | 24 | 0.130 |
Why?
|
| Periodicity | 1 | 2016 | 58 | 0.130 |
Why?
|
| Bone Marrow | 1 | 2018 | 304 | 0.130 |
Why?
|
| Foot Diseases | 1 | 1996 | 17 | 0.130 |
Why?
|
| Liver Neoplasms | 3 | 2016 | 780 | 0.130 |
Why?
|
| Culture Media | 2 | 2021 | 161 | 0.130 |
Why?
|
| Brain Injuries | 1 | 2022 | 507 | 0.130 |
Why?
|
| Mammals | 3 | 2023 | 293 | 0.130 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 203 | 0.130 |
Why?
|
| Femoral Fractures | 1 | 2017 | 82 | 0.120 |
Why?
|
| Immunologic Factors | 1 | 2019 | 255 | 0.120 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 383 | 0.120 |
Why?
|
| Flow Cytometry | 3 | 2018 | 1173 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2024 | 380 | 0.120 |
Why?
|
| Protein Folding | 1 | 2018 | 279 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 623 | 0.120 |
Why?
|
| Color | 2 | 2019 | 81 | 0.120 |
Why?
|
| Specimen Handling | 2 | 2021 | 186 | 0.120 |
Why?
|
| Riboflavin | 2 | 2014 | 15 | 0.120 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 920 | 0.120 |
Why?
|
| Hydrogen Sulfide | 1 | 2016 | 48 | 0.120 |
Why?
|
| Discriminant Analysis | 1 | 2016 | 36 | 0.120 |
Why?
|
| DNA | 1 | 2023 | 1463 | 0.120 |
Why?
|
| Health Status | 2 | 2019 | 836 | 0.120 |
Why?
|
| Myocytes, Cardiac | 1 | 2021 | 556 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 3 | 2023 | 919 | 0.120 |
Why?
|
| Succinate Dehydrogenase | 3 | 2022 | 57 | 0.120 |
Why?
|
| Orthomyxoviridae | 1 | 2016 | 40 | 0.120 |
Why?
|
| T-Lymphocytes | 3 | 2019 | 1982 | 0.120 |
Why?
|
| Marijuana Smoking | 1 | 2019 | 250 | 0.120 |
Why?
|
| Phosphatidylethanolamines | 1 | 2016 | 76 | 0.120 |
Why?
|
| Anxiety | 1 | 2023 | 1109 | 0.120 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 300 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 151 | 0.120 |
Why?
|
| Diabetic Retinopathy | 1 | 2018 | 208 | 0.120 |
Why?
|
| Body Temperature | 1 | 2016 | 229 | 0.120 |
Why?
|
| Sesquiterpenes | 2 | 2016 | 52 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2020 | 707 | 0.110 |
Why?
|
| Monocytes | 3 | 2023 | 538 | 0.110 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2024 | 609 | 0.110 |
Why?
|
| Anoikis | 1 | 2015 | 30 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 2925 | 0.110 |
Why?
|
| Hydroxylysine | 1 | 2015 | 4 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 510 | 0.110 |
Why?
|
| Brassicaceae | 1 | 2015 | 3 | 0.110 |
Why?
|
| Phosphatidylcholines | 1 | 2016 | 131 | 0.110 |
Why?
|
| Taurocholic Acid | 1 | 2015 | 8 | 0.110 |
Why?
|
| Glutarates | 2 | 2025 | 11 | 0.110 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 3 | 2021 | 48 | 0.110 |
Why?
|
| Lower Extremity | 1 | 2019 | 438 | 0.110 |
Why?
|
| Nijmegen Breakage Syndrome | 1 | 2014 | 1 | 0.110 |
Why?
|
| Drug Design | 2 | 2019 | 173 | 0.110 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2015 | 60 | 0.110 |
Why?
|
| Adolescent | 17 | 2024 | 22428 | 0.110 |
Why?
|
| Heart Arrest | 2 | 2016 | 407 | 0.110 |
Why?
|
| Stroke | 1 | 2024 | 1256 | 0.110 |
Why?
|
| Protein Binding | 4 | 2026 | 2273 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2021 | 846 | 0.110 |
Why?
|
| Kallikreins | 1 | 2014 | 25 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2022 | 159 | 0.110 |
Why?
|
| Tissue Banks | 1 | 1994 | 17 | 0.110 |
Why?
|
| Acute-Phase Proteins | 1 | 2014 | 67 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 156 | 0.110 |
Why?
|
| Extinction, Biological | 1 | 2015 | 38 | 0.110 |
Why?
|
| Platelet Activation | 3 | 2024 | 104 | 0.110 |
Why?
|
| Peptide Fragments | 3 | 2013 | 699 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 2115 | 0.110 |
Why?
|
| Serine Proteases | 1 | 2014 | 26 | 0.110 |
Why?
|
| Europe | 1 | 2015 | 412 | 0.110 |
Why?
|
| Factor XIII | 2 | 2026 | 15 | 0.110 |
Why?
|
| Immunotherapy | 3 | 2024 | 653 | 0.110 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 636 | 0.110 |
Why?
|
| Neutrophil Activation | 1 | 2014 | 85 | 0.110 |
Why?
|
| Molecular Chaperones | 1 | 2016 | 200 | 0.110 |
Why?
|
| Intestines | 1 | 2017 | 358 | 0.110 |
Why?
|
| Structure-Activity Relationship | 3 | 2021 | 570 | 0.110 |
Why?
|
| Glycoproteins | 2 | 2013 | 355 | 0.100 |
Why?
|
| Sequence Deletion | 1 | 2014 | 193 | 0.100 |
Why?
|
| Cations | 1 | 2014 | 82 | 0.100 |
Why?
|
| Thrombolytic Therapy | 1 | 2015 | 163 | 0.100 |
Why?
|
| Free Radical Scavengers | 1 | 2014 | 82 | 0.100 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2014 | 56 | 0.100 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2012 | 179 | 0.100 |
Why?
|
| Parasitic Diseases | 1 | 2014 | 8 | 0.100 |
Why?
|
| Parkinson Disease | 1 | 2020 | 600 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2014 | 300 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 148 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 64 | 0.100 |
Why?
|
| Seasons | 1 | 2016 | 556 | 0.100 |
Why?
|
| Peptide Hydrolases | 1 | 2014 | 105 | 0.100 |
Why?
|
| Tumor Protein p73 | 1 | 2013 | 18 | 0.100 |
Why?
|
| Adrenal Glands | 1 | 2014 | 77 | 0.100 |
Why?
|
| Cannabis | 1 | 2021 | 509 | 0.100 |
Why?
|
| CRISPR-Cas Systems | 2 | 2025 | 170 | 0.100 |
Why?
|
| Fat Body | 2 | 2026 | 8 | 0.100 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 5868 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2018 | 760 | 0.100 |
Why?
|
| Acetylcysteine | 1 | 2014 | 139 | 0.100 |
Why?
|
| Hyperplasia | 1 | 2014 | 174 | 0.100 |
Why?
|
| Epidermal Growth Factor | 2 | 2004 | 171 | 0.100 |
Why?
|
| Ultraviolet Rays | 2 | 2014 | 388 | 0.100 |
Why?
|
| Phosphatidylinositols | 1 | 2013 | 57 | 0.100 |
Why?
|
| Fetal Growth Retardation | 3 | 2025 | 587 | 0.100 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2023 | 80 | 0.100 |
Why?
|
| Mothers | 4 | 2021 | 775 | 0.100 |
Why?
|
| Peptides | 1 | 2019 | 995 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 1318 | 0.100 |
Why?
|
| Proteins | 3 | 2023 | 1021 | 0.100 |
Why?
|
| Glucose Tolerance Test | 3 | 2021 | 361 | 0.100 |
Why?
|
| Postmortem Changes | 1 | 2012 | 17 | 0.100 |
Why?
|
| Child | 15 | 2026 | 22633 | 0.100 |
Why?
|
| Platelet Aggregation | 2 | 2025 | 105 | 0.100 |
Why?
|
| Infant, Premature | 1 | 2017 | 611 | 0.100 |
Why?
|
| Adipocytes | 2 | 2025 | 223 | 0.090 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 291 | 0.090 |
Why?
|
| Ascorbic Acid | 1 | 2014 | 180 | 0.090 |
Why?
|
| Interferon-alpha | 2 | 2004 | 197 | 0.090 |
Why?
|
| Gamma Rays | 1 | 2013 | 56 | 0.090 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2013 | 120 | 0.090 |
Why?
|
| Photosensitizing Agents | 1 | 2013 | 42 | 0.090 |
Why?
|
| Cytoplasm | 1 | 2013 | 269 | 0.090 |
Why?
|
| Collagen | 1 | 2015 | 456 | 0.090 |
Why?
|
| Doping in Sports | 1 | 2012 | 5 | 0.090 |
Why?
|
| Taste Buds | 1 | 2015 | 212 | 0.090 |
Why?
|
| Autoimmunity | 3 | 2024 | 926 | 0.090 |
Why?
|
| Phosphoric Acids | 1 | 2012 | 17 | 0.090 |
Why?
|
| Peroxiredoxins | 1 | 2012 | 26 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2014 | 229 | 0.090 |
Why?
|
| Protein Domains | 2 | 2026 | 313 | 0.090 |
Why?
|
| Stem Cells | 3 | 2021 | 626 | 0.090 |
Why?
|
| Cell Extracts | 1 | 2012 | 21 | 0.090 |
Why?
|
| Multiple Organ Failure | 2 | 2022 | 124 | 0.090 |
Why?
|
| Mental Disorders | 1 | 2021 | 1168 | 0.090 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 172 | 0.090 |
Why?
|
| Pyruvate Dehydrogenase Complex | 2 | 2025 | 9 | 0.090 |
Why?
|
| Embryo Culture Techniques | 1 | 2011 | 11 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2023 | 722 | 0.090 |
Why?
|
| Genetic Background | 2 | 2021 | 16 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 1053 | 0.090 |
Why?
|
| Botrytis | 1 | 2011 | 2 | 0.090 |
Why?
|
| Crops, Agricultural | 1 | 2011 | 31 | 0.090 |
Why?
|
| Resorcinols | 1 | 2011 | 5 | 0.090 |
Why?
|
| Embryo Implantation | 1 | 2011 | 30 | 0.090 |
Why?
|
| Wine | 1 | 2011 | 13 | 0.090 |
Why?
|
| Adenoma | 1 | 2014 | 218 | 0.090 |
Why?
|
| Plant Diseases | 1 | 2011 | 44 | 0.090 |
Why?
|
| Embryo Transfer | 1 | 2011 | 37 | 0.090 |
Why?
|
| Sus scrofa | 1 | 2011 | 64 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 845 | 0.090 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 2 | 2025 | 16 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 592 | 0.090 |
Why?
|
| Vitis | 1 | 2011 | 28 | 0.090 |
Why?
|
| Virus Diseases | 1 | 2014 | 216 | 0.090 |
Why?
|
| Calibration | 1 | 2012 | 151 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 1496 | 0.090 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2018 | 199 | 0.090 |
Why?
|
| Stilbenes | 1 | 2011 | 33 | 0.090 |
Why?
|
| Benzofurans | 1 | 2011 | 26 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 442 | 0.090 |
Why?
|
| Food Microbiology | 1 | 2011 | 73 | 0.090 |
Why?
|
| Datasets as Topic | 2 | 2022 | 122 | 0.090 |
Why?
|
| Lung Transplantation | 1 | 1995 | 338 | 0.090 |
Why?
|
| Protein Carbonylation | 1 | 2011 | 57 | 0.090 |
Why?
|
| Ovalbumin | 2 | 2024 | 190 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2013 | 313 | 0.090 |
Why?
|
| Trastuzumab | 2 | 2022 | 118 | 0.080 |
Why?
|
| Colorado | 2 | 2021 | 4564 | 0.080 |
Why?
|
| Bile Duct Diseases | 1 | 2011 | 13 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 557 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 320 | 0.080 |
Why?
|
| Academic Medical Centers | 2 | 2007 | 547 | 0.080 |
Why?
|
| Survival Analysis | 5 | 2016 | 1382 | 0.080 |
Why?
|
| Living Donors | 3 | 2008 | 280 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 2027 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 5 | 2022 | 3890 | 0.080 |
Why?
|
| Myofibrils | 2 | 2021 | 49 | 0.080 |
Why?
|
| Embryonic Development | 1 | 2011 | 125 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 497 | 0.080 |
Why?
|
| Retrospective Studies | 13 | 2022 | 17066 | 0.080 |
Why?
|
| Phenols | 1 | 2011 | 114 | 0.080 |
Why?
|
| Aquaporin 4 | 1 | 2011 | 98 | 0.080 |
Why?
|
| United States | 5 | 2023 | 15966 | 0.080 |
Why?
|
| Databases, Protein | 1 | 2010 | 90 | 0.080 |
Why?
|
| Fertility | 1 | 2011 | 168 | 0.080 |
Why?
|
| Longevity | 2 | 2022 | 173 | 0.080 |
Why?
|
| Forecasting | 1 | 2012 | 391 | 0.080 |
Why?
|
| Erythroblastosis, Fetal | 1 | 2010 | 5 | 0.080 |
Why?
|
| Cell Shape | 1 | 2010 | 57 | 0.080 |
Why?
|
| Nucleotides | 2 | 2023 | 128 | 0.080 |
Why?
|
| Cell Size | 1 | 2010 | 92 | 0.080 |
Why?
|
| RNA, Small Interfering | 3 | 2017 | 635 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 1180 | 0.080 |
Why?
|
| Child, Preschool | 9 | 2024 | 11787 | 0.080 |
Why?
|
| Breeding | 1 | 2009 | 63 | 0.080 |
Why?
|
| Chickens | 1 | 2010 | 191 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2011 | 202 | 0.080 |
Why?
|
| HCT116 Cells | 2 | 2020 | 78 | 0.070 |
Why?
|
| Bisphosphoglycerate Mutase | 2 | 2021 | 7 | 0.070 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2009 | 73 | 0.070 |
Why?
|
| Neuronal Plasticity | 2 | 2023 | 309 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2017 | 158 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2011 | 770 | 0.070 |
Why?
|
| Immunologic Memory | 2 | 2025 | 366 | 0.070 |
Why?
|
| Glucose Clamp Technique | 2 | 2021 | 199 | 0.070 |
Why?
|
| Fibrosis | 2 | 2023 | 548 | 0.070 |
Why?
|
| Regional Blood Flow | 2 | 2024 | 514 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2023 | 220 | 0.070 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2009 | 80 | 0.070 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2010 | 169 | 0.070 |
Why?
|
| Sulfones | 2 | 2020 | 127 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2022 | 402 | 0.070 |
Why?
|
| Metabolism | 2 | 2019 | 44 | 0.070 |
Why?
|
| Raffinose | 7 | 1999 | 29 | 0.070 |
Why?
|
| Complement Activation | 2 | 2022 | 411 | 0.070 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2024 | 239 | 0.070 |
Why?
|
| Allopurinol | 7 | 1999 | 69 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 340 | 0.070 |
Why?
|
| Survival Rate | 6 | 2025 | 2089 | 0.070 |
Why?
|
| Antagomirs | 2 | 2017 | 12 | 0.070 |
Why?
|
| Cell Movement | 3 | 2017 | 965 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 1996 | 1098 | 0.070 |
Why?
|
| Risk Factors | 6 | 2023 | 10779 | 0.070 |
Why?
|
| Models, Animal | 2 | 2021 | 392 | 0.070 |
Why?
|
| Monocarboxylic Acid Transporters | 2 | 2017 | 21 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2020 | 847 | 0.070 |
Why?
|
| Caspase 1 | 2 | 2018 | 148 | 0.070 |
Why?
|
| Heterozygote | 2 | 2021 | 315 | 0.060 |
Why?
|
| Ubiquitination | 2 | 2018 | 118 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 2025 | 955 | 0.060 |
Why?
|
| Cell Division | 2 | 2026 | 766 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1985 | 0.060 |
Why?
|
| Kinetics | 2 | 2022 | 1627 | 0.060 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2018 | 213 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2021 | 946 | 0.060 |
Why?
|
| Wisconsin | 4 | 2007 | 99 | 0.060 |
Why?
|
| 5'-Nucleotidase | 2 | 2017 | 49 | 0.060 |
Why?
|
| GPI-Linked Proteins | 2 | 2017 | 80 | 0.060 |
Why?
|
| Binding Sites | 2 | 2021 | 1329 | 0.060 |
Why?
|
| Cell Adhesion | 2 | 2018 | 455 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 432 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2018 | 682 | 0.060 |
Why?
|
| Osmotic Fragility | 2 | 2018 | 12 | 0.060 |
Why?
|
| International Normalized Ratio | 1 | 2026 | 49 | 0.060 |
Why?
|
| Pupa | 1 | 2025 | 14 | 0.060 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2026 | 23 | 0.060 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2025 | 33 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2024 | 365 | 0.060 |
Why?
|
| Bolivia | 1 | 2025 | 61 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 2 | 2022 | 760 | 0.060 |
Why?
|
| Hemodynamics | 2 | 2021 | 1121 | 0.060 |
Why?
|
| Glycerol | 2 | 2018 | 90 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2019 | 1003 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2021 | 784 | 0.060 |
Why?
|
| Lipolysis | 1 | 2025 | 46 | 0.060 |
Why?
|
| Skin Diseases, Genetic | 1 | 2025 | 13 | 0.060 |
Why?
|
| eIF-2 Kinase | 1 | 2025 | 29 | 0.060 |
Why?
|
| Cytarabine | 1 | 2025 | 66 | 0.060 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 688 | 0.060 |
Why?
|
| Organ Specificity | 1 | 2026 | 312 | 0.060 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2025 | 70 | 0.060 |
Why?
|
| Species Specificity | 3 | 2011 | 574 | 0.060 |
Why?
|
| Phagosomes | 1 | 2025 | 40 | 0.060 |
Why?
|
| RAW 264.7 Cells | 1 | 2025 | 50 | 0.060 |
Why?
|
| Blast Crisis | 1 | 2025 | 35 | 0.060 |
Why?
|
| Sarcolemma | 2 | 2018 | 38 | 0.050 |
Why?
|
| Hepatitis C | 1 | 2008 | 254 | 0.050 |
Why?
|
| Proline Oxidase | 1 | 2024 | 6 | 0.050 |
Why?
|
| Erythroid Cells | 1 | 2024 | 8 | 0.050 |
Why?
|
| Carbohydrate Metabolism | 1 | 2025 | 60 | 0.050 |
Why?
|
| Cysteamine | 1 | 2024 | 7 | 0.050 |
Why?
|
| Mitochondrial Dynamics | 1 | 2025 | 40 | 0.050 |
Why?
|
| Pulse Wave Analysis | 1 | 2026 | 266 | 0.050 |
Why?
|
| Liver Diseases | 2 | 2021 | 304 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2024 | 21 | 0.050 |
Why?
|
| Follow-Up Studies | 7 | 2016 | 5408 | 0.050 |
Why?
|
| Clone Cells | 1 | 2025 | 266 | 0.050 |
Why?
|
| Heme Oxygenase-1 | 1 | 2025 | 74 | 0.050 |
Why?
|
| Drug Repositioning | 1 | 2024 | 41 | 0.050 |
Why?
|
| Microbial Viability | 1 | 2025 | 90 | 0.050 |
Why?
|
| Dioxygenases | 1 | 2024 | 36 | 0.050 |
Why?
|
| Simvastatin | 1 | 2024 | 60 | 0.050 |
Why?
|
| Premenopause | 1 | 2025 | 123 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2025 | 209 | 0.050 |
Why?
|
| Germinal Center | 1 | 2024 | 67 | 0.050 |
Why?
|
| Indoleacetic Acids | 1 | 2024 | 10 | 0.050 |
Why?
|
| Fenofibrate | 1 | 2024 | 28 | 0.050 |
Why?
|
| Hydro-Lyases | 1 | 2024 | 7 | 0.050 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2004 | 55 | 0.050 |
Why?
|
| Complement Pathway, Mannose-Binding Lectin | 1 | 2024 | 23 | 0.050 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2025 | 139 | 0.050 |
Why?
|
| Syndrome | 1 | 2025 | 380 | 0.050 |
Why?
|
| Multipotent Stem Cells | 1 | 2024 | 21 | 0.050 |
Why?
|
| Janus Kinase 2 | 1 | 2024 | 29 | 0.050 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2024 | 150 | 0.050 |
Why?
|
| Plastics | 1 | 2024 | 47 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2024 | 62 | 0.050 |
Why?
|
| Hyaluronic Acid | 1 | 2026 | 208 | 0.050 |
Why?
|
| Aerosols | 1 | 2025 | 186 | 0.050 |
Why?
|
| Cotinine | 1 | 2024 | 79 | 0.050 |
Why?
|
| Pneumococcal Infections | 1 | 2025 | 103 | 0.050 |
Why?
|
| Fish Oils | 1 | 2023 | 26 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2024 | 116 | 0.050 |
Why?
|
| Respiratory Therapy | 1 | 2023 | 25 | 0.050 |
Why?
|
| Ranolazine | 1 | 2023 | 25 | 0.050 |
Why?
|
| Dapsone | 1 | 2023 | 8 | 0.050 |
Why?
|
| Smoking | 2 | 2024 | 1472 | 0.050 |
Why?
|
| TRPV Cation Channels | 1 | 2023 | 43 | 0.050 |
Why?
|
| Maltose | 1 | 2023 | 8 | 0.050 |
Why?
|
| Peptide Initiation Factors | 1 | 2003 | 16 | 0.050 |
Why?
|
| Brachial Artery | 1 | 2025 | 206 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 1720 | 0.050 |
Why?
|
| A549 Cells | 1 | 2023 | 75 | 0.050 |
Why?
|
| Monitoring, Immunologic | 1 | 2023 | 23 | 0.050 |
Why?
|
| Metabolic Engineering | 1 | 2023 | 36 | 0.050 |
Why?
|
| Pantothenic Acid | 1 | 2023 | 5 | 0.050 |
Why?
|
| Thromboplastin | 1 | 2023 | 69 | 0.050 |
Why?
|
| Acyl Coenzyme A | 1 | 2023 | 31 | 0.050 |
Why?
|
| Transplantation, Homologous | 5 | 2011 | 415 | 0.050 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2023 | 40 | 0.050 |
Why?
|
| Factor V | 1 | 2023 | 26 | 0.050 |
Why?
|
| Sildenafil Citrate | 1 | 2023 | 60 | 0.050 |
Why?
|
| 1-Acylglycerophosphocholine O-Acyltransferase | 1 | 2022 | 5 | 0.050 |
Why?
|
| Ventricular Function, Right | 1 | 2025 | 297 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2023 | 65 | 0.050 |
Why?
|
| Dasatinib | 1 | 2023 | 57 | 0.050 |
Why?
|
| Guanine | 1 | 2003 | 87 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2025 | 601 | 0.050 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2023 | 60 | 0.050 |
Why?
|
| Inosine | 1 | 2022 | 14 | 0.050 |
Why?
|
| Arginase | 1 | 2022 | 27 | 0.050 |
Why?
|
| Blood Coagulation Tests | 1 | 2023 | 70 | 0.050 |
Why?
|
| Iodine Radioisotopes | 1 | 2023 | 136 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2026 | 596 | 0.050 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2022 | 4 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2023 | 177 | 0.050 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2022 | 25 | 0.050 |
Why?
|
| Hand Strength | 1 | 2023 | 144 | 0.050 |
Why?
|
| Genome, Human | 1 | 2025 | 422 | 0.050 |
Why?
|
| Myocardium | 2 | 2019 | 939 | 0.050 |
Why?
|
| PQQ Cofactor | 1 | 2022 | 5 | 0.050 |
Why?
|
| Volunteers | 1 | 2022 | 39 | 0.050 |
Why?
|
| Malates | 1 | 2022 | 7 | 0.050 |
Why?
|
| Leukocytes | 2 | 2017 | 295 | 0.050 |
Why?
|
| Fumarates | 1 | 2022 | 10 | 0.050 |
Why?
|
| Pyrimidinones | 1 | 2023 | 126 | 0.050 |
Why?
|
| Citrulline | 1 | 2022 | 46 | 0.050 |
Why?
|
| Patient Selection | 4 | 2015 | 719 | 0.050 |
Why?
|
| Carboxylic Acids | 1 | 2022 | 34 | 0.050 |
Why?
|
| Solvents | 1 | 2002 | 113 | 0.050 |
Why?
|
| Histidine | 1 | 2022 | 66 | 0.050 |
Why?
|
| Sputum | 1 | 2024 | 308 | 0.050 |
Why?
|
| Catalase | 1 | 2022 | 130 | 0.040 |
Why?
|
| Spermine | 1 | 2022 | 29 | 0.040 |
Why?
|
| Ovarian Follicle | 1 | 1982 | 73 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2025 | 3671 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2022 | 86 | 0.040 |
Why?
|
| Gram-Negative Bacteria | 1 | 2022 | 81 | 0.040 |
Why?
|
| Phenylalanine | 1 | 2022 | 71 | 0.040 |
Why?
|
| Disease Resistance | 1 | 2021 | 29 | 0.040 |
Why?
|
| Caspases | 2 | 2018 | 232 | 0.040 |
Why?
|
| Thyroid Nodule | 1 | 2002 | 56 | 0.040 |
Why?
|
| Animals, Wild | 1 | 2021 | 61 | 0.040 |
Why?
|
| Ketone Oxidoreductases | 1 | 2021 | 7 | 0.040 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2021 | 4 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 2021 | 43 | 0.040 |
Why?
|
| X-Ray Diffraction | 1 | 2021 | 103 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2024 | 436 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2021 | 74 | 0.040 |
Why?
|
| Synaptic Transmission | 1 | 2024 | 290 | 0.040 |
Why?
|
| Phospholipids | 1 | 2023 | 213 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2021 | 100 | 0.040 |
Why?
|
| Plasmodium falciparum | 1 | 2021 | 39 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2021 | 162 | 0.040 |
Why?
|
| Drug Resistance, Multiple | 1 | 2021 | 25 | 0.040 |
Why?
|
| Pyridones | 1 | 2023 | 199 | 0.040 |
Why?
|
| Nephritis | 1 | 2021 | 22 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 232 | 0.040 |
Why?
|
| Pyridines | 1 | 2026 | 605 | 0.040 |
Why?
|
| Binding, Competitive | 2 | 2019 | 193 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2022 | 144 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2025 | 560 | 0.040 |
Why?
|
| Wechsler Scales | 1 | 2021 | 59 | 0.040 |
Why?
|
| Ranitidine | 1 | 2021 | 14 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2021 | 139 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2022 | 162 | 0.040 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2021 | 26 | 0.040 |
Why?
|
| Social Problems | 1 | 2021 | 10 | 0.040 |
Why?
|
| Frailty | 1 | 2024 | 198 | 0.040 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2021 | 19 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2021 | 104 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2024 | 1266 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2025 | 439 | 0.040 |
Why?
|
| Hypoalbuminemia | 1 | 2021 | 28 | 0.040 |
Why?
|
| Membrane Microdomains | 1 | 2021 | 34 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2021 | 11 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2023 | 281 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2021 | 74 | 0.040 |
Why?
|
| Access to Information | 1 | 2021 | 48 | 0.040 |
Why?
|
| gamma-Glutamyl Hydrolase | 1 | 2020 | 3 | 0.040 |
Why?
|
| Albuminuria | 1 | 2022 | 190 | 0.040 |
Why?
|
| Comorbidity | 3 | 2021 | 1658 | 0.040 |
Why?
|
| Birth Weight | 1 | 2024 | 522 | 0.040 |
Why?
|
| Arctic Regions | 1 | 2020 | 15 | 0.040 |
Why?
|
| Phenylephrine | 1 | 2021 | 75 | 0.040 |
Why?
|
| Oncogenes | 1 | 2021 | 119 | 0.040 |
Why?
|
| Behavior Observation Techniques | 1 | 2020 | 10 | 0.040 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2020 | 31 | 0.040 |
Why?
|
| Glycine | 1 | 2022 | 187 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2023 | 331 | 0.040 |
Why?
|
| Granulocytes | 1 | 2021 | 80 | 0.040 |
Why?
|
| Erucic Acids | 1 | 2020 | 3 | 0.040 |
Why?
|
| Candidiasis | 1 | 2021 | 64 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2021 | 111 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2023 | 264 | 0.040 |
Why?
|
| Presenilin-1 | 1 | 2020 | 33 | 0.040 |
Why?
|
| Serum Response Factor | 1 | 2021 | 33 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 139 | 0.040 |
Why?
|
| Hematologic Tests | 1 | 2020 | 21 | 0.040 |
Why?
|
| Linoleic Acid | 1 | 2021 | 44 | 0.040 |
Why?
|
| Postoperative Complications | 7 | 2000 | 2919 | 0.040 |
Why?
|
| Intelligence | 1 | 2021 | 112 | 0.040 |
Why?
|
| Spatial Memory | 1 | 2020 | 28 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2021 | 64 | 0.040 |
Why?
|
| Intercellular Junctions | 1 | 2020 | 35 | 0.040 |
Why?
|
| Bacteriophage lambda | 1 | 2021 | 90 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2014 | 1187 | 0.040 |
Why?
|
| Sarcomeres | 1 | 2021 | 98 | 0.040 |
Why?
|
| Cochlea | 1 | 2021 | 73 | 0.040 |
Why?
|
| Point Mutation | 1 | 2021 | 243 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 172 | 0.040 |
Why?
|
| Ferritins | 1 | 2020 | 69 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 573 | 0.040 |
Why?
|
| Quality of Life | 3 | 2023 | 3185 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2020 | 64 | 0.040 |
Why?
|
| Ovary | 1 | 1982 | 228 | 0.040 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2020 | 89 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2023 | 330 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 336 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2024 | 449 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2021 | 246 | 0.040 |
Why?
|
| Data Mining | 1 | 2021 | 117 | 0.040 |
Why?
|
| Action Potentials | 1 | 2023 | 506 | 0.040 |
Why?
|
| Biomimetic Materials | 1 | 2021 | 76 | 0.040 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 2020 | 12 | 0.040 |
Why?
|
| Nootropic Agents | 1 | 2020 | 30 | 0.040 |
Why?
|
| Mitochondria, Liver | 1 | 2020 | 70 | 0.040 |
Why?
|
| Drug Therapy | 1 | 2020 | 80 | 0.040 |
Why?
|
| Psoriasis | 1 | 2021 | 112 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2021 | 196 | 0.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 35 | 0.040 |
Why?
|
| Permeability | 1 | 2020 | 168 | 0.040 |
Why?
|
| Exome | 1 | 2021 | 227 | 0.040 |
Why?
|
| Acetylation | 1 | 2021 | 252 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2020 | 397 | 0.040 |
Why?
|
| Ubiquinone | 1 | 2020 | 35 | 0.040 |
Why?
|
| Quinolinic Acid | 1 | 2019 | 7 | 0.040 |
Why?
|
| Niacinamide | 1 | 2020 | 86 | 0.040 |
Why?
|
| Protein Stability | 1 | 2020 | 178 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 135 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2019 | 3 | 0.040 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 36 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 2020 | 81 | 0.040 |
Why?
|
| Biosynthetic Pathways | 1 | 2019 | 25 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 389 | 0.040 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2019 | 47 | 0.040 |
Why?
|
| Object Attachment | 1 | 2020 | 48 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2021 | 185 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 1489 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2020 | 106 | 0.040 |
Why?
|
| Chromatin | 1 | 2024 | 561 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2026 | 916 | 0.040 |
Why?
|
| Megakaryocytes | 1 | 2019 | 34 | 0.040 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2019 | 6 | 0.040 |
Why?
|
| Technetium | 1 | 2019 | 10 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 462 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2021 | 171 | 0.040 |
Why?
|
| Carbocyanines | 1 | 2019 | 36 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2004 | 641 | 0.040 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2019 | 19 | 0.040 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2019 | 4 | 0.040 |
Why?
|
| Phylogeny | 1 | 2023 | 1016 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 191 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 114 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2018 | 6 | 0.040 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2018 | 13 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2020 | 151 | 0.040 |
Why?
|
| Cryoprotective Agents | 1 | 2018 | 11 | 0.040 |
Why?
|
| 3' Flanking Region | 1 | 2018 | 7 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 2000 | 298 | 0.040 |
Why?
|
| Tricarboxylic Acids | 1 | 2018 | 11 | 0.040 |
Why?
|
| DNA Damage | 1 | 2022 | 430 | 0.040 |
Why?
|
| Hindlimb | 1 | 2019 | 131 | 0.040 |
Why?
|
| Ketoglutaric Acids | 1 | 2018 | 23 | 0.040 |
Why?
|
| Terpenes | 1 | 2018 | 25 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2019 | 170 | 0.040 |
Why?
|
| Water | 1 | 2022 | 469 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2018 | 33 | 0.040 |
Why?
|
| Aerobiosis | 1 | 2018 | 22 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2021 | 397 | 0.040 |
Why?
|
| Maternal Age | 1 | 2019 | 126 | 0.040 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2018 | 17 | 0.040 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2019 | 84 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2019 | 93 | 0.040 |
Why?
|
| Ataxia Telangiectasia | 1 | 2018 | 18 | 0.040 |
Why?
|
| Sulfhydryl Compounds | 1 | 2020 | 189 | 0.040 |
Why?
|
| Vaccinia | 1 | 2018 | 20 | 0.040 |
Why?
|
| Macaca | 1 | 2018 | 65 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 83 | 0.040 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2018 | 39 | 0.040 |
Why?
|
| Alanine | 1 | 2019 | 171 | 0.040 |
Why?
|
| Thioredoxins | 1 | 2018 | 30 | 0.040 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2018 | 17 | 0.030 |
Why?
|
| Caspases, Initiator | 1 | 2018 | 17 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2018 | 193 | 0.030 |
Why?
|
| Ligands | 1 | 2020 | 673 | 0.030 |
Why?
|
| Liver X Receptors | 1 | 2018 | 30 | 0.030 |
Why?
|
| Immunosuppressive Agents | 3 | 1999 | 846 | 0.030 |
Why?
|
| Hospitals, University | 2 | 1999 | 176 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2020 | 426 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2018 | 60 | 0.030 |
Why?
|
| Purine Nucleotides | 1 | 2018 | 12 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2021 | 405 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 510 | 0.030 |
Why?
|
| Gluconeogenesis | 1 | 2018 | 83 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2018 | 58 | 0.030 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2017 | 17 | 0.030 |
Why?
|
| Interleukin-15 | 1 | 2018 | 97 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 202 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 389 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 758 | 0.030 |
Why?
|
| Dopamine | 1 | 2020 | 283 | 0.030 |
Why?
|
| Methods | 1 | 2017 | 69 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2017 | 41 | 0.030 |
Why?
|
| Lim Kinases | 1 | 2017 | 5 | 0.030 |
Why?
|
| Smad5 Protein | 1 | 2017 | 7 | 0.030 |
Why?
|
| Glycogen Phosphorylase | 1 | 2017 | 2 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 371 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2024 | 684 | 0.030 |
Why?
|
| Naphthoquinones | 1 | 2017 | 19 | 0.030 |
Why?
|
| Smad1 Protein | 1 | 2017 | 17 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2001 | 370 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2020 | 307 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 68 | 0.030 |
Why?
|
| Ethanol | 1 | 2002 | 627 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 177 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2020 | 536 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 965 | 0.030 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2017 | 52 | 0.030 |
Why?
|
| Logistic Models | 1 | 2022 | 2117 | 0.030 |
Why?
|
| Inpatients | 1 | 2022 | 545 | 0.030 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2017 | 41 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2018 | 232 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2021 | 395 | 0.030 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2017 | 30 | 0.030 |
Why?
|
| Symporters | 1 | 2017 | 48 | 0.030 |
Why?
|
| Microcirculation | 1 | 2017 | 138 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2020 | 519 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2017 | 15 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2017 | 122 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 464 | 0.030 |
Why?
|
| Cytosol | 1 | 2018 | 227 | 0.030 |
Why?
|
| Solubility | 1 | 2017 | 242 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 154 | 0.030 |
Why?
|
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2021 | 514 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 358 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2018 | 213 | 0.030 |
Why?
|
| Pulse | 1 | 1996 | 27 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 2018 | 245 | 0.030 |
Why?
|
| Dysbiosis | 1 | 2018 | 187 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 2017 | 85 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2024 | 847 | 0.030 |
Why?
|
| Weaning | 1 | 2016 | 46 | 0.030 |
Why?
|
| Prevalence | 1 | 2024 | 2834 | 0.030 |
Why?
|
| Interleukins | 1 | 2018 | 248 | 0.030 |
Why?
|
| Drug Combinations | 2 | 2011 | 390 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2019 | 202 | 0.030 |
Why?
|
| Sensation | 1 | 1996 | 55 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2018 | 650 | 0.030 |
Why?
|
| Hydrazines | 1 | 2016 | 37 | 0.030 |
Why?
|
| Interleukin-18 | 1 | 2018 | 235 | 0.030 |
Why?
|
| Attention | 1 | 2020 | 457 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 8265 | 0.030 |
Why?
|
| Foot Injuries | 1 | 1996 | 23 | 0.030 |
Why?
|
| Bronchioles | 1 | 2016 | 29 | 0.030 |
Why?
|
| Drug Overdose | 1 | 2021 | 370 | 0.030 |
Why?
|
| Myoblasts | 1 | 2017 | 84 | 0.030 |
Why?
|
| Fetal Hemoglobin | 1 | 2016 | 8 | 0.030 |
Why?
|
| Pancreas | 2 | 1999 | 341 | 0.030 |
Why?
|
| Preoperative Care | 2 | 1996 | 379 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 2016 | 51 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2016 | 49 | 0.030 |
Why?
|
| Adventitia | 1 | 2016 | 43 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 125 | 0.030 |
Why?
|
| Tacrolimus | 1 | 1997 | 196 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 42 | 0.030 |
Why?
|
| Triglycerides | 1 | 2018 | 520 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1137 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2016 | 81 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 157 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2016 | 99 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2016 | 67 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 299 | 0.030 |
Why?
|
| Donor Selection | 1 | 2016 | 79 | 0.030 |
Why?
|
| Blood Viscosity | 1 | 2015 | 18 | 0.030 |
Why?
|
| Foot | 1 | 1996 | 100 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 652 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2017 | 319 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 266 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2019 | 627 | 0.030 |
Why?
|
| Renal Dialysis | 2 | 1996 | 462 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 2015 | 84 | 0.030 |
Why?
|
| Neuroendocrine Tumors | 1 | 1997 | 112 | 0.030 |
Why?
|
| Bison | 1 | 2015 | 6 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2015 | 124 | 0.030 |
Why?
|
| Drainage | 2 | 1993 | 185 | 0.030 |
Why?
|
| Allergens | 1 | 2018 | 384 | 0.030 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2015 | 89 | 0.030 |
Why?
|
| Workflow | 1 | 2017 | 184 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 1519 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2017 | 247 | 0.030 |
Why?
|
| Blood Circulation | 1 | 2015 | 44 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 767 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 331 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2019 | 532 | 0.030 |
Why?
|
| X-Rays | 1 | 2014 | 31 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 1996 | 222 | 0.030 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 1994 | 2 | 0.030 |
Why?
|
| Elasticity | 1 | 2015 | 184 | 0.030 |
Why?
|
| Cholangitis, Sclerosing | 1 | 1995 | 60 | 0.030 |
Why?
|
| Heart | 1 | 2019 | 636 | 0.030 |
Why?
|
| Body Size | 1 | 2015 | 95 | 0.030 |
Why?
|
| Thoracotomy | 1 | 2015 | 83 | 0.030 |
Why?
|
| Sirolimus | 1 | 2016 | 281 | 0.030 |
Why?
|
| Glycosylation | 1 | 2015 | 172 | 0.030 |
Why?
|
| Microscopy, Electrochemical, Scanning | 1 | 2014 | 1 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 940 | 0.030 |
Why?
|
| Arsenites | 1 | 2014 | 6 | 0.030 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2014 | 6 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 397 | 0.030 |
Why?
|
| Biopsy | 1 | 2018 | 1075 | 0.030 |
Why?
|
| Homozygote | 1 | 2014 | 199 | 0.030 |
Why?
|
| Furocoumarins | 1 | 2014 | 8 | 0.030 |
Why?
|
| Genotype | 1 | 2019 | 1833 | 0.030 |
Why?
|
| Postoperative Care | 2 | 1993 | 288 | 0.030 |
Why?
|
| Cholangiocarcinoma | 1 | 1995 | 105 | 0.030 |
Why?
|
| F-Box Proteins | 1 | 2014 | 23 | 0.030 |
Why?
|
| Trypsinogen | 1 | 1994 | 11 | 0.030 |
Why?
|
| Hypertension, Portal | 1 | 1994 | 66 | 0.030 |
Why?
|
| Tranexamic Acid | 1 | 2015 | 53 | 0.030 |
Why?
|
| Aldosterone | 1 | 2014 | 43 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 1257 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 197 | 0.030 |
Why?
|
| Skull | 1 | 2015 | 158 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 592 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 370 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2015 | 205 | 0.030 |
Why?
|
| Exercise Test | 1 | 2017 | 634 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2016 | 365 | 0.030 |
Why?
|
| Adiposity | 1 | 2018 | 543 | 0.030 |
Why?
|
| Isoelectric Focusing | 1 | 2013 | 30 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 1047 | 0.020 |
Why?
|
| Urologic Diseases | 1 | 1993 | 40 | 0.020 |
Why?
|
| Photochemistry | 1 | 2014 | 134 | 0.020 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1993 | 19 | 0.020 |
Why?
|
| Hemostasis | 1 | 2014 | 102 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2014 | 248 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 676 | 0.020 |
Why?
|
| Tissue Preservation | 1 | 1992 | 12 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 192 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2017 | 477 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2012 | 52 | 0.020 |
Why?
|
| Technology, Pharmaceutical | 1 | 2012 | 30 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2016 | 1126 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2012 | 55 | 0.020 |
Why?
|
| Drug Contamination | 1 | 2012 | 52 | 0.020 |
Why?
|
| Dithiothreitol | 1 | 2011 | 19 | 0.020 |
Why?
|
| Registries | 2 | 2016 | 2385 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2012 | 327 | 0.020 |
Why?
|
| Atracurium | 1 | 1991 | 14 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 1994 | 634 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 1996 | 414 | 0.020 |
Why?
|
| Pneumonia | 1 | 2017 | 631 | 0.020 |
Why?
|
| Complement C4b | 1 | 2011 | 9 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2011 | 85 | 0.020 |
Why?
|
| Dystrophin | 1 | 2011 | 39 | 0.020 |
Why?
|
| Conalbumin | 1 | 1990 | 3 | 0.020 |
Why?
|
| Family | 1 | 1995 | 679 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 104 | 0.020 |
Why?
|
| Hospitalization | 1 | 2021 | 2433 | 0.020 |
Why?
|
| Quadriceps Muscle | 1 | 2011 | 118 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 1993 | 441 | 0.020 |
Why?
|
| Hemophilia A | 1 | 2011 | 147 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1991 | 194 | 0.020 |
Why?
|
| Diabetic Nephropathies | 4 | 1999 | 318 | 0.020 |
Why?
|
| Neuromuscular Diseases | 1 | 1991 | 146 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1989 | 71 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2008 | 85 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2008 | 106 | 0.020 |
Why?
|
| Incidence | 3 | 2001 | 2879 | 0.010 |
Why?
|
| History, 21st Century | 1 | 2007 | 219 | 0.010 |
Why?
|
| Nephrectomy | 2 | 1998 | 158 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2007 | 325 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2004 | 53 | 0.010 |
Why?
|
| Program Development | 1 | 2007 | 370 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 1135 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 238 | 0.010 |
Why?
|
| KB Cells | 1 | 2003 | 4 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 138 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 175 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2002 | 125 | 0.010 |
Why?
|
| Leucine | 1 | 1982 | 116 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 292 | 0.010 |
Why?
|
| Cysts | 1 | 2002 | 111 | 0.010 |
Why?
|
| Oocytes | 1 | 1982 | 178 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2003 | 310 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2001 | 183 | 0.010 |
Why?
|
| Probability | 1 | 2001 | 310 | 0.010 |
Why?
|
| Muromonab-CD3 | 1 | 1998 | 6 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2001 | 1325 | 0.010 |
Why?
|
| Mycophenolic Acid | 1 | 1998 | 120 | 0.010 |
Why?
|
| Cause of Death | 1 | 2000 | 471 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2001 | 1462 | 0.010 |
Why?
|
| Bile | 1 | 1997 | 26 | 0.010 |
Why?
|
| Perfusion | 1 | 1998 | 250 | 0.010 |
Why?
|
| Potassium | 1 | 1997 | 152 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 1996 | 121 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 166 | 0.010 |
Why?
|
| Splenectomy | 1 | 1996 | 65 | 0.010 |
Why?
|
| Sodium | 1 | 1997 | 197 | 0.010 |
Why?
|
| Reoperation | 1 | 1999 | 630 | 0.010 |
Why?
|
| Colectomy | 1 | 1995 | 107 | 0.010 |
Why?
|
| Amylases | 1 | 1994 | 18 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1994 | 53 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 458 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1995 | 259 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1994 | 354 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 1991 | 64 | 0.010 |
Why?
|
| Employment | 1 | 1993 | 188 | 0.010 |
Why?
|
| Thyroidectomy | 1 | 1991 | 91 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1990 | 132 | 0.010 |
Why?
|
| Attitude to Health | 1 | 1993 | 436 | 0.000 |
Why?
|
| Heart Diseases | 1 | 1989 | 349 | 0.000 |
Why?
|